SEALED AIR CORPORATION
(Exact name of registrant as specified in its charter)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ý No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No ý

There were 159,680,387 shares of the registrant's common stock, par value $0.10 per share, issued and outstanding as of October 31, 2010.

SEALED AIR CORPORATION AND SUBSIDIARIES
FORM 10-Q
FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2010
TABLE OF CONTENTS

SEALED AIR CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In millions, except per share amounts)

			Three Months Ended September 30,						Nine Months Ended September 30,

			2010			2009			2010			2009
Net sales:
	Food Packaging		$	483.4		$	463.4		$	1,390.0		$	1,336.1
	Food Solutions			240.4			229.6			687.7			655.0
	Protective Packaging			327.0			306.1			954.4			868.0
	Other			79.2			80.8			248.8			237.3

		Total net sales		1,130.0			1,079.9			3,280.9			3,096.4
Cost of sales				809.5			768.8			2,359.9			2,211.5

	Gross profit			320.5			311.1			921.0			884.9
Marketing, administrative and development expenses				173.3			180.0			520.4			515.5
Restructuring and other charges				0.1			0.9			0.4			1.2

	Operating profit			147.1			130.2			400.2			368.2
Interest expense				(40.7	)		(41.9	)		(122.4	)		(114.6	)
Net gains on sale (other-than-temporary impairment) of available-for-sale securities				2.0			(3.2	)		2.4			(3.2	)
Foreign currency exchange (losses) gains related to Venezuelan subsidiary				(1.3	)		—			6.5			—
Loss on debt redemption				—			(3.4	)		—			(3.4	)
Other expense, net				(1.6	)		(2.4	)		(2.5	)		(4.2	)

	Earnings before income tax provision			105.5			79.3			284.2			242.8
Income tax provision				29.0			18.7			79.6			63.6

	Net earnings available to common stockholders		$	76.5		$	60.6		$	204.6		$	179.2

Net earnings per common share:
	Basic		$	0.48		$	0.38		$	1.29		$	1.13

	Diluted		$	0.43		$	0.34		$	1.15		$	0.99

Dividends per common share			$	0.13		$	0.12		$	0.37		$	0.36

Weighted average number of common shares outstanding:
	Basic			158.3			157.4			158.2			157.1

	Diluted			176.7			178.3			176.4			184.9

SEALED AIR CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In millions, except share data)

		September 30, 2010			December 31, 2009

		(Unaudited)
Assets
Current assets:
	Cash and cash equivalents	$	761.8		$	694.5
	Receivables, net of allowance for doubtful accounts of $21.1 in 2010 and $17.5 in 2009		691.9			666.7
	Inventories		539.1			469.4
	Deferred tax assets		188.7			176.1
	Prepaid expenses and other current assets		38.1			66.7

Total current assets			2,219.6			2,073.4
Property and equipment, net			965.3			1,010.7
Goodwill			1,947.8			1,948.7
Non-current deferred tax assets			162.5			146.0
Other assets, net			276.4			241.3

Total assets		$	5,571.6		$	5,420.1

Liabilities and stockholders' equity
Current liabilities:
	Short-term borrowings	$	19.7		$	28.2
	Current portion of long-term debt		8.6			6.5
	Accounts payable		238.2			214.2
	Deferred tax liabilities		8.6			8.0
	Settlement agreement and related accrued interest		777.6			746.8
	Accrued restructuring costs		2.2			15.8
	Other current liabilities		390.2			414.3

	Total current liabilities		1,445.1			1,433.8
Long-term debt, less current portion			1,559.6			1,626.3
Non-current deferred tax liabilities			7.5			6.4
Other liabilities			160.8			153.3

Total liabilities			3,173.0			3,219.8
Commitments and contingencies
Stockholders' equity:
	Preferred stock, $0.10 par value per share, 50,000,000 shares authorized; no shares issued in 2010 and 2009		—			—
	Common stock, $0.10 par value per share, 400,000,000 shares authorized; shares issued: 169,144,886 in 2010 and 168,749,681 in 2009; shares outstanding: 159,611,987 in 2010 and 158,938,174 in 2009		16.9			16.9
	Common stock reserved for issuance related to Settlement agreement, $0.10 par value per share, 18,000,000 shares in 2010 and 2009		1.8			1.8
	Additional paid-in capital		1,144.3			1,127.1
	Retained earnings		1,675.9			1,531.1
	Common stock in treasury, 9,532,899 shares in 2010 and 9,811,507 shares in 2009		(352.9	)		(364.6	)
Accumulated other comprehensive loss, net of taxes:
	Unrecognized pension items		(64.6	)		(70.4	)
	Cumulative translation adjustment		(30.5	)		(50.8	)
	Unrealized gain on derivative instruments		4.0			4.1
	Unrealized gain on available-for-sale securities		4.6			4.4

	Total accumulated other comprehensive loss, net of taxes		(86.5	)		(112.7	)

Total parent company stockholders' equity			2,399.5			2,199.6
Non-controlling interests			(0.9	)		0.7

Total stockholders' equity			2,398.6			2,200.3

Total liabilities and stockholders' equity		$	5,571.6		$	5,420.1

SEALED AIR CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In millions)

			Nine Months Ended September 30,

			2010			2009
Cash flows from operating activities:
Net earnings			$	204.6		$	179.2
Adjustments to reconcile net earnings to net cash provided by operating activities:
	Depreciation and amortization			114.0			113.8
	Share-based compensation			22.0			21.4
	Amortization of senior debt related items and other			1.3			1.5
	Loss on debt redemption			—			3.4
	(Net gains on sale) other-than-temporary impairment of available-for-sale securities			(2.4	)		3.2
	Provisions for bad debt			6.0			3.5
	Provisions for inventory obsolescence			2.2			7.0
	Deferred taxes, net			(11.0	)		(20.7	)
	Net gain on disposals of property and equipment and other			(0.4	)		(1.7	)
Changes in operating assets and liabilities, net of effects of businesses acquired:
	Receivables, net			(26.4	)		98.0
	Accounts receivable securitization program			—			(80.0	)
	Inventories			(62.4	)		68.8
	Other assets, net			16.2			(2.3	)
	Accounts payable			23.3			(56.1	)
	Income taxes payable			29.2			(10.5	)
	Other liabilities			(27.0	)		30.2

	Net cash provided by operating activities			289.2			358.7

Cash flows from investing activities:
	Capital expenditures for property and equipment			(60.7	)		(60.2	)
	Businesses acquired in purchase transaction, net of cash and cash equivalents acquired			(7.6	)		(0.7	)
	Proceeds from sale of available-for-sale securities			6.2			—
	Proceeds from sales of property and equipment			3.1			2.1
	Other investing activities			2.1			1.5

	Net cash used in investing activities			(56.9	)		(57.3	)

Cash flows from financing activities:
	Payments of long-term debt			(79.5	)		(583.9	)
	Proceeds from long-term debt			—			703.8
	Dividends paid on common stock			(59.0	)		(57.1	)
	Net payments of short-term borrowings			(8.0	)		(7.6	)
	Payment of debt issuance costs			—			(7.0	)
	Other			(2.0	)		—

	Net cash (used in) provided by financing activities			(148.5	)		48.2

Effect of foreign currency exchange rate changes on cash and cash equivalents				(16.5	)		8.6

Cash and cash equivalents:
	Balance, beginning of period		$	694.5		$	128.9
	Net change during the period			67.3			358.2

	Balance, end of period		$	761.8		$	487.1

Supplemental Cash Flow Information:
	Interest payments, net of amounts capitalized		$	106.1		$	85.2

	Income tax payments		$	63.6		$	90.1

	Non-cash items:
		Transfers of shares of our common stock from treasury as part of our 2009 and 2008 profit-sharing plan contributions	$	7.2		$	5.9

		Net unrealized gains on available-for-sale securities	$	0.2		$	6.3

SEALED AIR CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

(In millions)

		Three Months Ended September 30,					Nine Months Ended September 30,

		2010		2009			2010			2009
Net earnings available to common stockholders		$	76.5	$	60.6		$	204.6		$	179.2
Other comprehensive income, net of income taxes:
	Recognition of deferred pension items, net of income tax provision of $0.5 for the three months ended September 30, 2010, $0.4 for the three months ended September 30, 2009, $1.2 for the nine months ended September 30, 2010 and $1.2 for the nine months ended September 30, 2009		2.2		1.9			5.8			5.5
	Unrealized gains (losses) on derivative instruments, net of income tax (provision) benefit of $(0.1) for the three months ended September 30, 2010, $0.1 for the nine months ended September 30, 2010 and $0.3 in 2009		0.2		—			(0.1	)		(0.6	)
	Unrealized losses on available-for-sale securities, reclassified to net earnings, net of income tax benefit of $0.7 for the three and nine months ended September 30, 2009 and $0.1 in 2010		—		(1.1	)		(0.1	)		(1.1	)
	Unrealized gains on available-for-sale securities, net of income tax provision of $0.1 in 2010, $0.6 for the three months ended September 30, 2009 and $3.0 for the nine months ended September 30, 2009		—		1.2			0.3			5.1
	Foreign currency translation adjustments		108.3		50.3			20.3			88.6

Comprehensive income, net of income taxes		$	187.2	$	112.9		$	230.8		$	276.7

SEALED AIR CORPORATION AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(Unaudited)

(Amounts in tables are in millions, except per share data)

We are a leading global innovator and manufacturer of a wide range of packaging and performance-based materials and equipment systems that serve an array of food, industrial, medical and consumer applications.

We conduct substantially all of our business through two direct wholly-owned subsidiaries, Cryovac, Inc. and Sealed Air Corporation (US). These two subsidiaries, directly and indirectly, own substantially all of the assets of the business and conduct operations themselves and through subsidiaries around the world. We adopted this corporate structure in connection with the Cryovac transaction. See "Cryovac Transaction Commitments and Contingencies," of Note 14, "Commitments and Contingencies," for a description of the Cryovac transaction and related terms used in these Notes to Condensed Consolidated Financial Statements. Throughout this report, when we refer to "Sealed Air," the "Company," "we," "our," or "us," we are referring to Sealed Air Corporation and all of our subsidiaries, except where the context indicates otherwise.

Our condensed consolidated financial statements include all of the accounts of the Company and our subsidiaries. We have eliminated all significant intercompany transactions and balances in consolidation. In management's opinion, all adjustments, consisting only of normal recurring accruals, necessary for a fair presentation of our condensed consolidated balance sheet as of September 30, 2010 and our condensed consolidated statements of operations for the three and nine months ended September 30, 2010 and 2009 have been made. The results set forth in our condensed consolidated statements of operations for the three and nine months ended September 30, 2010 and in our condensed consolidated statements of cash flows for the nine months ended September 30, 2010 and 2009 are not necessarily indicative of the results to be expected for the full year. All amounts are approximate due to rounding. Some prior period amounts have been reclassified to conform to the current year presentation. These reclassifications, individually and in the aggregate, had no impact on our consolidated financial position, results of operations and cash flows.

Our condensed consolidated financial statements were prepared following the interim reporting requirements of the Securities and Exchange Commission, or the SEC. As permitted under those rules, annual footnotes or other financial information that are normally required by accounting principles generally accepted in the United States of America, or U.S. GAAP, have been condensed or omitted. The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in our condensed consolidated financial statements and accompanying notes. Actual results could differ from these estimates.

We are responsible for the unaudited condensed consolidated financial statements and notes included in this document. As these are condensed financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and with the information contained in other publicly-available filings with the SEC.

In January 2010, the FASB issued an amendment to accounting standards addressing fair value measurements and disclosures which requires reporting entities to make new disclosures about recurring and non-recurring fair-value measurements, including significant transfers into and out of Level 1 and Level 2 fair-value measurements and information about purchases, sales, issuances, and settlements on a gross basis in the reconciliation of Level 3 fair-value measurements. The revised accounting standard also clarifies existing fair-value measurement disclosure guidance about the level of disaggregation, inputs and valuation techniques. The adoption of this new standard in 2010 did not impact our consolidated financial position or results of operations as it is disclosure-only in nature.

In June 2009, the FASB issued new accounting standards relating to the transfer of financial assets. These standards require entities to provide more information regarding sales of securitized financial assets and similar transactions, particularly if the entity has continuing exposure to the risks related to transferred financial assets. They also eliminate the concept of a "qualifying special-purpose entity," change the requirements for derecognizing financial assets and require additional disclosures. We adopted this standard on January 1, 2010. In the future, any transfers of ownership interests of receivables under our receivables securitization program to the issuer of commercial paper or to the participating bank are no longer considered sales of receivables but are considered secured borrowings and will be recorded as liabilities on our consolidated balance sheets. See Note 6, "Accounts Receivable Securitization Program," for additional information about this program.

Also, in June 2009, the FASB issued new accounting standards which change how a company determines when an entity that is insufficiently capitalized or is not controlled through voting (or similar rights) should be consolidated. The determination of whether a company is required to consolidate an entity is based on, among other things, an entity's purpose and design and a company's ability to direct the activities of the entity that most significantly impact the entity's economic performance. These standards were effective beginning January 1, 2010. The adoption of this new standard in 2010 did not impact our consolidated financial position or results of operations.

In September 2009, the FASB ratified an amendment to accounting standards addressing revenue recognition for arrangements with multiple revenue-generating activities. The amendment addresses how revenue should be allocated to separate elements that could impact the timing of revenue recognition. The amendment is effective for us on a prospective basis for revenue arrangements entered into or materially modified on or after January 1, 2011, and earlier application is permitted. We may elect, but are not required, to apply the standards retrospectively to all prior periods. We are currently evaluating the impact this amendment may have on our consolidated financial position and results of operations.

The following table shows net sales, depreciation and amortization and operating profit by our segment reporting structure.

		Three Months Ended September 30,				Nine Months Ended September 30,

		2010		2009		2010		2009
Net sales
	Food Packaging	$	483.4	$	463.4	$	1,390.0	$	1,336.1
	Food Solutions		240.4		229.6		687.7		655.0
	Protective Packaging		327.0		306.1		954.4		868.0
	Other		79.2		80.8		248.8		237.3

	Total	$	1,130.0	$	1,079.9	$	3,280.9	$	3,096.4

Depreciation and amortization(1)
	Food Packaging	$	17.2	$	17.2	$	53.2	$	51.3
	Food Solutions		7.4		8.0		22.6		22.9
	Protective Packaging		7.6		8.6		23.0		25.5
	Other		5.2		5.4		15.2		14.1

	Total	$	37.4	$	39.2	$	114.0	$	113.8

Operating profit(2)
	Food Packaging	$	70.3	$	63.5	$	184.3	$	184.5
	Food Solutions		27.5		21.4		71.5		66.3
	Protective Packaging		46.7		41.4		131.5		108.1
	Other		2.7		4.8		13.3		10.5

	Total segments and other		147.2		131.1		400.6		369.4
	Restructuring and other charges(3)		0.1		0.9		0.4		1.2

	Total	$	147.1	$	130.2	$	400.2	$	368.2

The following table shows assets allocated to our reportable segments. Only assets which are identifiable by segment and reviewed by our chief operating decision maker by segment are allocated to

the reportable segment assets, which are trade receivables, net, and finished goods inventories, net. All other assets are included in "Assets not allocated." Assets not allocated include goodwill of $1,947.8 million at September 30, 2010 and $1,948.7 million at December 31, 2009 and total property and equipment, net, of $965.3 million at September 30, 2010 and $1,010.7 million at December 31, 2009.

Our management views goodwill as a corporate asset, so we do not allocate our goodwill balance to our reportable segments. However, we are required to allocate goodwill to each reporting unit to perform our annual impairment review of goodwill under U.S. GAAP, which we do during the fourth quarter of the year. See Note 9, "Goodwill and Identifiable Intangible Assets," for the allocation of goodwill and the changes in goodwill balances in the nine months ended September 30, 2010 by our reporting unit structure.

(4) Global Manufacturing Strategy and 2008 Cost Reduction and Productivity Program

We announced our global manufacturing strategy program, or GMS, in 2006. The goals of this multi-year program were to realign our manufacturing footprint to expand capacity in growing markets, to further improve our operating efficiencies, and to implement new technologies more effectively. Additionally, we have been optimizing certain manufacturing platforms in North America and Europe into centers of excellence. By taking advantage of new technologies and streamlining production on a global scale, we have continued to enhance our profitable growth and our global leadership position and have produced meaningful benefits.

In 2009, we opened a new manufacturing facility in Duchnice, Poland. This facility along with our other new facilities in Qingpu, China and Monterrey, Mexico completed the construction phase related

(4) Global Manufacturing Strategy and 2008 Cost Reduction and Productivity Program (Continued)

to this program. We anticipate an additional $1 million of costs in the fourth quarter of 2010 related to completing our GMS program.

The capital expenditures, associated costs and related restructuring charges and the total amounts incurred since inception of this multi-year strategy are included in the table below.

The components of the restructuring accrual for GMS through September 30, 2010 and the accrual balance remaining on our condensed consolidated balance sheet at September 30, 2010 were as follows:

(4) Global Manufacturing Strategy and 2008 Cost Reduction and Productivity Program (Continued)

We expect to pay the accrual balance remaining at September 30, 2010 within the next 12 months. This amount is included in other current liabilities on our condensed consolidated balance sheet at September 30, 2010.

In 2008, we implemented a cost reduction and productivity program. The components of the restructuring accrual related to this program through September 30, 2010 and the accrual balance remaining on our condensed consolidated balance sheet at September 30, 2010 are included in the table below.

The following table summarizes our year to date activity on our investments in available-for-sale securities:

In 2010, we sold four of our five auction rate security investments. These four investments had a combined total original cost of $32.7 million. Beginning in the second half of 2007 through the date of sale of these four securities in the second and third quarters of 2010, we recognized other-than-temporary impairments for cumulative pre-tax losses of $29.6 million. Total proceeds received on the sale of these four securities in 2010 were $6.2 million, resulting in gains of $3.1 million in 2010. These gains reduced our total cumulative pre-tax losses on these investments to $26.5 million ($16.7 million, net of taxes).

At September 30, 2010, we had one remaining auction rate security investment, which continues to be exposed to market risk related to changes in conditions in the U.S. financial markets and in the

financial condition of the security's issuer. This security historically was re-auctioned every twenty-eight days, which had provided a liquid market for it. However, as a result of continuing liquidity concerns in the U.S. for this type of asset-backed security, every auction held by the issuer since late 2007 has failed. This investment had an original cost of $12.0 million and an estimated fair value of $10.1 million at September 30, 2010.

The following table details our interest and dividend payments received from our auction rate securities investments for the three and nine months ended September 30, 2010 and 2009.

See Note 12, "Fair Value Measurements and Other Financial Instruments," for details on the inputs and valuation methodology used to calculate the estimated fair value of these investments.

We continue to monitor developments in the market for auction rate securities. If credit or liquidity conditions relating to this security or the issuer worsen, we may recognize additional other-than-temporary impairments, which would result in the recognition of additional losses on our condensed consolidated statement of operations.

We and a group of our U.S. subsidiaries maintain an accounts receivable securitization program with a bank and an issuer of commercial paper administered by the bank. As of September 30, 2010, the maximum purchase limit for receivable interests was $125.0 million, subject to the availability limits described below.

The amounts available from time to time under the program may be less than $125.0 million due to a number of factors, including but not limited to our credit ratings, accounts receivable balances, the creditworthiness of our customers and our receivables collection experience. During the nine months ended September 30, 2010, the level of eligible assets available under the program was lower than $125.0 million primarily due to our current credit rating. As a result, the amount available to us under the program was approximately $95 million at September 30, 2010. Although we do not believe that these restrictive provisions presently materially restrict our operations, if an additional event occurs that triggers one of these restrictive provisions, we could experience a further decline in the amounts available under the program or termination of the program.

As of September 30, 2010 and December 31, 2009, we had no amounts outstanding under this program and we did not utilize this program during 2010.

The overall program is scheduled to expire in December 2012; however, the program includes a bank financing commitment that must be renewed annually. The bank financing commitment is scheduled to expire on December 3, 2010. We plan to seek an additional 364 day renewal of the bank commitment before its expiration. While the bank is not obligated to renew the bank financing commitment, we have negotiated annual renewals since the commencement of the program in 2001.

Under limited circumstances, the bank and the issuer of commercial paper can end purchases of receivables interests before the above dates. A downgrade of our long-term senior unsecured debt to BB- or below by Standard & Poor's Rating Services or Ba3 or below by Moody's Investors Service, Inc., or failure to comply with interest coverage, debt leverage ratios or various other ratios related to our receivables collection experience could result in termination of the receivables program. We were in compliance with both the credit rating provisions and these ratios at September 30, 2010 and December 31, 2009.

Other expense, net, includes the costs associated with our receivables securitization program. These costs primarily relate to program fees, commitment fees, other associated costs and the losses on the sale of the undivided ownership interests in 2009, all of which totaled $0.2 million for the three months ended September 30, 2010, $0.6 million for the nine months ended September 30, 2010, $0.1 million for the three months ended September 30, 2009 and $0.6 million for the nine months ended September 30, 2009.

As a result of our adoption of new accounting standards related to the transfer of financial assets on January 1, 2010, any transfers of ownership interests in receivables under this program will be considered secured borrowings and will be recorded as liabilities on our condensed consolidated balance sheets. Also, the costs associated with this program related to program fees on any outstanding borrowings under this program will now be included in interest expense, and the costs related to commitment fees on the unused portion of this program will continue to be included in other expense, net, on our condensed consolidated statements of operations.

The following table details our inventories and the reduction of certain inventories to a LIFO basis:

We determine the value of non-equipment U.S. inventories by the last-in, first-out or LIFO inventory method. U.S. inventories determined by the LIFO method were $120.0 million at September 30, 2010, $111.2 million at December 31, 2009 and $116.1 million at September 30, 2009.

The following table details our property and equipment, net, at September 30, 2010 and December 31, 2009.

The following table details our interest cost capitalized and depreciation and amortization expense for property and equipment for the three and nine months ended September 30, 2010 and 2009.

The following table shows our goodwill balances at September 30, 2010 and December 31, 2009 by our reporting unit structure.

		Carrying Value at December 31, 2009		Impact of Foreign Currency Translation			Carrying Value at September 30, 2010

Food Packaging segment		$	383.6	$	(0.2	)	$	383.4
Food Solutions segment			148.1		(0.1	)		148.0
Protective Packaging segment:
	Protective Packaging		1,145.9		(0.5	)		1,145.4
	Shrink Packaging		115.3		(0.1	)		115.2

Total Protective Packaging segment			1,261.2		(0.6	)		1,260.6
Other:
	Specialty Materials		110.1		—			110.1
	Medical Applications		45.7		—			45.7
	New Ventures		—		—			—

Total Other			155.8		—			155.8

Total Company		$	1,948.7	$	(0.9	)	$	1,947.8

We test goodwill for impairment on a reporting unit basis annually during the fourth quarter of each year and at other times if events or circumstances exist that indicate the carrying value of goodwill may no longer be recoverable. During the nine months ended September 30, 2010, we determined that there were no events or changes in circumstances that occurred that would indicate that the fair value of any of our reporting units may be below its carrying value.

The following tables summarize our identifiable intangible assets with definite and indefinite useful lives.

Identifiable intangible assets are included in other assets, net, on our condensed consolidated balance sheets. These include $31.0 million of intangible assets that we have determined to have indefinite useful lives.

Below is the amortization expense of our intangible assets for the 2010 and 2009 periods. This expense is included in marketing, administrative and development expenses on our condensed consolidated statements of operations.

At September 30, 2010, the remaining estimated future amortization expense is as follows:

Our total debt outstanding consisted of the amounts set forth on the following table:

		September 30, 2010		December 31, 2009

Short-term borrowings		$	19.7	$	28.2
Current portion of long-term debt			8.6		6.5

Total current debt			28.3		34.7
	5.625% Senior Notes due July 2013, less unamortized discount of $0.4 in 2010 and $0.6 in 2009		399.6		399.4
	12% Senior Notes due February 2014(1), (2)		311.2		299.5
	7.875% Senior Notes due June 2017, less unamortized discount of $7.6 in 2010 and $8.2 in 2009		392.4		391.8
	6.875% Senior Notes due July 2033, less unamortized discount of $1.5 in 2010 and 2009		448.5		448.5
	Other		7.9		87.1

Total long-term debt, less current portion			1,559.6		1,626.3

Total debt		$	1,587.9	$	1,661.0

The following table summarizes our available lines of credit and committed and uncommitted lines of credit at September 30, 2010 and December 31, 2009, including the global credit facility and European credit facility, which are discussed below, and the amounts available under our accounts receivable securitization program. Our principal credit lines were committed and consisted of the global

credit facility and the European credit facility. We are not subject to any material compensating balance requirements in connection with our lines of credit.

The global credit facility is available for general corporate purposes, including the payment of amounts required to be paid upon the effectiveness of the Settlement agreement discussed in Note 14, "Commitments and Contingencies." We may re-borrow amounts repaid under the facility from time to time before the expiration or its earlier termination. Our obligations under the facility bear interest at floating rates, which are generally determined by adding the applicable borrowing margin to the base rate or the interbank rate for the relevant currency and time period. The facility provides for changes in borrowing margins based on our long-term senior unsecured debt ratings. The facility has an expiration date of July 26, 2012. As of September 30, 2010, the total amount available under the global credit facility was $472 million.

Facility fees are payable at the rate of 0.20% per annum on the total amounts available under the global credit facility. The facility provides for changes in fees based on our long-term senior unsecured debt ratings. Also, certain U.S. subsidiaries would be required to guarantee obligations under the facility if our long-term senior unsecured debt ratings by both Moody's and Standard & Poor's are below investment grade.

The terms of our global credit facility and our European credit facility, discussed below, include a requirement that, upon the occurrence of specified events that would adversely affect the Settlement agreement or would materially increase our liability in respect of the Grace bankruptcy or the asbestos liability arising from the Cryovac transaction, we would be required to repay any amounts outstanding under these facilities or refinance these facilities within 60 days.

At September 30, 2010, there were no amounts outstanding under this facility and we did not utilize this facility in the nine months ended September 30, 2010.

We have a €150 million European credit facility, equivalent to U.S. $204 million at September 30, 2010. The facility has an expiration date of July 26, 2012. A syndicate of banks made this facility available to Sealed Air and a group of our European subsidiaries for general corporate purposes, including the payment of amounts required to be paid upon effectiveness of the Settlement agreement. The terms of this facility are substantially similar to the terms of our global credit facility. We may re-borrow amounts repaid under the European credit facility from time to time before the expiration or earlier termination of the facility.

As of December 31, 2009, we had an outstanding balance of €45 million, which was equivalent to U.S. $64 million. We repaid this outstanding balance in January 2010. Interest expense related to the funds drawn in 2009 under this facility was $0.1 million in the nine months ended September 30, 2010 based on a weighted average interest rate of 3.625%. As of September 30, 2010, there were no amounts outstanding under this facility.

Substantially all our short-term borrowings of $19.7 million at September 30, 2010 and $28.2 million at December 31, 2009 were outstanding under lines of credit available to several of our foreign subsidiaries. The following table details our other lines of credit at September 30, 2010 and December 31, 2009:

Each issue of our outstanding senior notes imposes limitations on our operations and those of specified subsidiaries. The principal limitations restrict liens, sale and leaseback transactions and mergers, acquisitions and dispositions. Our global credit facility and our European credit facility contain financial covenants relating to interest coverage, debt leverage and minimum liquidity and restrictions on the creation of liens, the incurrence of additional indebtedness, acquisitions, mergers and consolidations, asset sales, and amendments to the Settlement agreement discussed above. We were in compliance with the above financial covenants and limitations, as applicable, at September 30, 2010 and December 31, 2009.

We report all derivative instruments on our balance sheet at fair value and establish criteria for designation and effectiveness of transactions entered into for hedging purposes.

As a large global organization, we face exposure to market risks, such as fluctuations in foreign currency exchange rates and interest rates. To manage the volatility relating to these exposures, we enter into various derivative instruments from time to time under our risk management policies. We

designate derivative instruments as hedges on a transaction basis to support hedge accounting. The changes in fair value of these hedging instruments offset in part or in whole corresponding changes in the fair value or cash flows of the underlying exposures being hedged. We assess the initial and ongoing effectiveness of our hedging relationships in accordance with our policy. We do not purchase, hold or sell derivative financial instruments for trading purposes. Our practice is to terminate derivative transactions if the underlying asset or liability matures or is sold or terminated, or if we determine the underlying forecasted transaction is no longer probable of occurring.

Our subsidiaries have foreign currency exchange exposure from buying and selling in currencies other than their functional currencies. The primary purposes of our foreign currency hedging activities are to manage the potential changes in value associated with the amounts receivable or payable on transactions denominated in foreign currencies and to minimize the impact of the changes in foreign currencies related to foreign currency denominated interest-bearing intercompany loans and receivables and payables. The changes in fair value of these contracts are recognized in other expense, net, on our condensed consolidated statements of operations and are largely offset by the remeasurement of the underlying foreign currency denominated items indicated above. These contracts have original maturities of less than 12 months.

At September 30, 2010, we were party to foreign currency forward contracts with an aggregate notional amount of $282.4 million maturing through August 2011. At December 31, 2009, we were party to foreign currency forward contracts with an aggregate notional amount of $282.8 million maturing through December 2010.

The estimated fair value of these contracts, which represents the estimated net payments that would be paid or that would be received by us in the event of their termination, based on the then current foreign currency exchange rates, was a net current asset of $2.5 million at September 30, 2010 and net current liability of $3.6 million at December 31, 2009. Any related net gains and losses were largely offset by the net losses and gains resulting from the remeasurement of the underlying foreign currency denominated transactions.

The primary purposes of our cash flow hedging activities are to manage the potential changes in value associated with the amounts receivable or payable on equipment and raw material purchases that are denominated in foreign currencies in order to minimize the impact of the changes in foreign currencies. We record gains and losses on foreign currency forward contracts qualifying as cash flow hedges in other comprehensive income to the extent that these hedges are effective and until we recognize the underlying transactions in net earnings, at which time we recognize these gains and losses in other expense, net, on our condensed consolidated statements of operations.

Net unrealized after tax gains (losses) related to these contracts that were included in other comprehensive income for the three and nine months ended September 30, 2010 and 2009 were immaterial. The unrealized amounts in other comprehensive income will fluctuate based on changes in the fair value of open contracts during each reporting period.

From time to time, we may use interest rate swaps to manage our mix of fixed and floating rates on outstanding indebtedness.

At September 30, 2010, we had outstanding interest rate swaps with a total notional amount of $200.0 million that qualified and were designated as fair value hedges. We entered into these interest rate swaps to effectively convert a portion of our 12% Senior Notes into floating rate debt. We recorded a mark to market adjustment to record an increase of $11.2 million at September 30, 2010 in the carrying amount of the 12% Senior Notes due to changes in interest rates and an offsetting increase to other assets at September 30, 2010 to record the fair value of the related interest rate swaps. There was no ineffective portion of the hedges recognized in earnings during the period.

At December 31, 2009, we recorded a mark to market adjustment to record a decrease of $0.5 million in the carrying amount of the 12% Senior Notes due to changes in interest rates and an offsetting increase to other liabilities at December 31, 2009 to record the fair value of the related interest rate swaps. There was no ineffective portion of the hedges recognized in earnings during the period.

In 2010, under the terms of the $200.0 million (notional amount) outstanding interest rate swap agreements, we received interest at a fixed rate and paid interest at variable rates that were based on the one-month London Interbank Offered Rate, or LIBOR. As a result, interest expense was reduced by $1.2 million in the three months ended September 30, 2010, $3.3 million in the nine months ended September 30, 2010 and $0.3 million in the three and nine months ended September 30, 2009.

We may use other derivative instruments from time to time, such as foreign exchange options to manage exposure due to foreign exchange rates and interest rate and currency swaps related to access to international financing transactions. These instruments can potentially limit foreign exchange exposure by swapping borrowings denominated in one currency for borrowings denominated in another currency. At September 30, 2010, we had no foreign exchange options or interest rate and currency swap agreements outstanding.

See Note 12, "Fair Value Measurements and Other Financial Instruments," for a discussion of the inputs and valuation techniques used to determine the fair value of our outstanding derivative instruments.

The following table details the fair value of our derivative instruments included on our condensed consolidated balance sheets.

The following table details the effect of our derivative instruments on our condensed consolidated statements of operations.

In determining fair value, we utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and consider counterparty credit risk in our assessment of fair value. Fair value measurement should be determined based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:

The following table shows a reconciliation of our available-for-sale securities, which are measured at fair value on a recurring basis using Level 3 inputs, as of September 30, 2010 (in millions):

Our cash equivalents at September 30, 2010 consisted of investments in U.S. Treasury obligations (fair value determined using Level 1 inputs) and investments in money market funds that invest in U.S. Treasury obligations (fair value determined using Level 2 inputs). Our cash equivalents at December 31, 2009 consisted of investments in commercial paper (fair value determined using Level 2 inputs). Since these are short-term highly liquid investments with original maturities of three months or less at the date of purchase, they present negligible risk of changes in fair value due to changes in interest rates.

At September 30, 2010, our available-for-sale security investment consisted of a debt instrument, which was recorded at fair value on our condensed consolidated balance sheets using an income approach valuation technique based on our interpretation by analysis and from related securities in secondary markets (Level 3 inputs).

Since this security does not currently have readily available or observable prices, we used the income approach to determine the fair value of this security. We calculated an estimated fair value for this investment using a bond calculation. The valuation methodology included the following inputs and assumptions:

Our valuation methodology calculation is subjective and involves uncertainties and matters of significant judgment. Changes in assumptions could significantly affect our estimates.

See Note 5, "Available-for-Sale Investments," for additional information on this security.

Our foreign currency forward contracts are recorded at fair value on our condensed consolidated balance sheets using the income approach valuation technique based on observable market inputs (Level 2).

Observable market inputs used in the calculation of the fair value of foreign currency forward contracts include foreign currency spot and forward rates obtained from an independent third party market data provider. In addition, other pricing data quoted by various banks and foreign currency dealers involving identical or comparable instruments are included.

Our interest rate swaps are recorded at fair value on our condensed consolidated balance sheet using the income approach valuation technique based on observable market inputs (Level 2). Observable market inputs used in the calculation of the fair value of interest rate swaps include pricing data from counterparties to these swaps, and a comparison is made to other market data including U.S. Treasury yields and swap spreads involving identical or comparable derivative instruments.

Counterparties to these foreign currency forward contracts and interest rate swaps are rated at least A- by Standard & Poor's and A3 by Moody's. None of these counterparties experienced any significant ratings downgrades in the nine months ended September 30, 2010. The fair value generally reflects the estimated amounts that we would receive or pay to terminate the contracts at the reporting date.

The following financial instruments are recorded at fair value or at amounts that approximate fair value: (1) receivables, net, (2) certain other current assets, (3) accounts payable and (4) other current liabilities. The carrying amounts reported on our condensed consolidated balance sheets for the above financial instruments closely approximate their fair value due to the short-term nature of these assets and liabilities.

Other liabilities that are recorded at carrying value on our condensed consolidated balance sheets include our senior notes. To calculate the fair value of our senior notes at September 30, 2010 and December 31, 2009, we utilized a market approach. Due to their limited investor base and the relatively small face value of each issue of the senior notes, they may not be actively traded on the date the fair value is calculated. Therefore, we utilize prices and other relevant information generated by market transactions involving similar securities, reflecting U.S. Treasury yields to calculate the yield to maturity and the price on each of our senior notes. These inputs are provided by an independent third party and are considered to be Level 2 inputs as described above.

We derived the fair value estimates of our various other debt instruments by evaluating the nature and terms of each instrument, considering prevailing economic and market conditions, and examining

the cost of similar debt offered at the balance sheet date. We also incorporated our credit default swap rates and currency specific swap rates in the valuation of each debt instrument, as applicable.

These estimates are subjective and involve uncertainties and matters of significant judgment, and therefore we cannot determine them with precision. Changes in assumptions could significantly affect our estimates.

The carrying amounts and estimated fair values of our debt at September 30, 2010 and December 31, 2009 were as follows:

Our effective income tax rate was 27.5% for the three months ended September 30, 2010 and 28.0% for the nine months ended September 30, 2010. Our effective income tax rate was 23.6% for the three months ended September 30, 2009 and 26.2% for the nine months ended September 30, 2009.

For the three months and nine months ended September 30, 2010, our effective income tax rate was lower than the statutory U.S. federal income tax rate of 35% primarily due to our lower net effective income tax rate on foreign earnings and our domestic manufacturing deduction, partially offset by state income taxes.

For the three months and nine months ended September 30, 2009, our effective income tax rate was lower than the statutory U.S. federal income tax rate of 35% primarily due to our lower net effective income tax rate on foreign earnings and the utilization of income tax credits for which no benefit had previously been recognized, partially offset by an increase in reserves relating to uncertain tax positions and state income taxes.

There have been no material changes to the Company's unrecognized tax benefits as reported at September 30, 2010, nor has the Company changed its policy with regard to the reporting of penalties and interest related to unrecognized tax benefits. Therefore, a reconciliation of unrecognized tax benefits from January 1, 2010 through September 30, 2010 has not been provided.

On November 27, 2002, we reached an agreement in principle with the Committees appointed to represent asbestos claimants in the bankruptcy case of W. R. Grace & Co., known as Grace, to resolve all current and future asbestos-related claims made against the Company and our affiliates in connection with the Cryovac transaction described below (as memorialized by the parties in the Settlement agreement and as approved by the Bankruptcy Court, the "Settlement agreement"). The Settlement agreement will also resolve the fraudulent transfer claims and successor liability claims, as well as indemnification claims by Fresenius Medical Care Holdings, Inc. and affiliated companies in connection with the Cryovac transaction. On December 3, 2002, our Board of Directors approved the agreement in principle. We received notice that both of the Committees had approved the agreement in principle as of December 5, 2002. The parties subsequently signed the definitive Settlement agreement as of November 10, 2003 consistent with the terms of the agreement in principle. For a description of the Cryovac transaction, asbestos-related claims and the parties involved, see "Cryovac Transaction" "Discussion of Cryovac Transaction Commitments and Contingencies," "Fresenius Claims," "Canadian Claims" and "Additional Matters Related to the Cryovac Transaction" below.

We recorded a pre-tax charge of $850.1 million as a result of the Settlement agreement on our condensed consolidated statement of operations for the year ended December 31, 2002. The charge consisted of the following items:

Settlement agreement and related costs reflected legal and related fees for Settlement-related matters of zero in the three months ended September 30, 2010, $0.6 million for the nine months ended September 30, 2010, $0.4 million for the three months ended September 30, 2009 and $1.2 million for the nine months ended September 30, 2009 which are included in other expense, net, on our condensed consolidated statements of operations.

On March 31, 1998, we completed a multi-step transaction that brought the Cryovac packaging business and the former Sealed Air Corporation's business under the common ownership of the Company. These businesses operate as subsidiaries of the Company, and the Company acts as a holding company. As part of that transaction, the parties separated the Cryovac packaging business, which previously had been held by various direct and indirect subsidiaries of the Company, from the remaining businesses previously held by the Company. The parties then arranged for the contribution of these remaining businesses to a company now known as W. R. Grace & Co., and the Company distributed the Grace shares to the Company's stockholders. As a result, W. R. Grace & Co. became a separate publicly owned company. The Company recapitalized its outstanding shares of common stock into a new common stock and a new convertible preferred stock. A subsidiary of the Company then merged into the former Sealed Air Corporation, which became a subsidiary of the Company and changed its name to Sealed Air Corporation (US).

In connection with the Cryovac transaction, Grace and its subsidiaries retained all liabilities arising out of their operations before the Cryovac transaction, whether accruing or occurring before or after the Cryovac transaction, other than liabilities arising from or relating to Cryovac's operations. Among the liabilities retained by Grace are liabilities relating to asbestos-containing products previously manufactured or sold by Grace's subsidiaries prior to the Cryovac transaction, including its primary U.S. operating subsidiary, W. R. Grace & Co.—Conn., which has operated for decades and has been a subsidiary of Grace since the Cryovac transaction. The Cryovac transaction agreements provided that, should any claimant seek to hold the Company or any of its subsidiaries responsible for liabilities

retained by Grace or its subsidiaries, including the asbestos-related liabilities, Grace and its subsidiaries would indemnify and defend us.

Since the beginning of 2000, we have been served with a number of lawsuits alleging that, as a result of the Cryovac transaction, we are responsible for alleged asbestos liabilities of Grace and its subsidiaries, some of which were also named as co-defendants in some of these actions. Among these lawsuits are several purported class actions and a number of personal injury lawsuits. Some plaintiffs seek damages for personal injury or wrongful death, while others seek medical monitoring, environmental remediation or remedies related to an attic insulation product. Neither the former Sealed Air Corporation nor Cryovac, Inc. ever produced or sold any of the asbestos-containing materials that are the subjects of these cases. None of these cases has reached resolution through judgment, settlement or otherwise. As discussed below, Grace's Chapter 11 bankruptcy proceeding has stayed all of these cases.

While the allegations in these actions directed to us vary, these actions all appear to allege that the transfer of the Cryovac business as part of the Cryovac transaction was a fraudulent transfer or gave rise to successor liability. Under a theory of successor liability, plaintiffs with claims against Grace and its subsidiaries may attempt to hold us liable for liabilities that arose with respect to activities conducted prior to the Cryovac transaction by W. R. Grace & Co.—Conn. or other Grace subsidiaries. A transfer would be a fraudulent transfer if the transferor received less than reasonably equivalent value and the transferor was insolvent or was rendered insolvent by the transfer, was engaged or was about to engage in a business for which its assets constitute unreasonably small capital, or intended to incur or believed that it would incur debts beyond its ability to pay as they mature. A transfer may also be fraudulent if it was made with actual intent to hinder, delay or defraud creditors. If a court found any transfers in connection with the Cryovac transaction to be fraudulent transfers, we could be required to return the property or its value to the transferor or could be required to fund liabilities of Grace or its subsidiaries for the benefit of their creditors, including asbestos claimants. We have reached an agreement in principle and subsequently signed the Settlement agreement, described below, that is expected to resolve all these claims.

In the Joint Proxy Statement furnished to their respective stockholders in connection with the Cryovac transaction, both parties to the transaction stated that it was their belief that Grace and its subsidiaries were adequately capitalized and would be adequately capitalized after the Cryovac transaction and that none of the transfers contemplated to occur in the Cryovac transaction would be a fraudulent transfer. They also stated their belief that the Cryovac transaction complied with other relevant laws. However, if a court applying the relevant legal standards had reached conclusions adverse to us, these determinations could have had a materially adverse effect on our consolidated financial position and results of operations.

On April 2, 2001, Grace and a number of its subsidiaries filed petitions for reorganization under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court in the District of Delaware. Grace stated that the filing was made in response to a sharply increasing number of asbestos claims since 1999.

In connection with its Chapter 11 filing, Grace filed an application with the Bankruptcy Court seeking to stay, among others, all actions brought against the Company and specified subsidiaries

related to alleged asbestos liabilities of Grace and its subsidiaries or alleging fraudulent transfer claims. The court issued an order dated May 3, 2001, which was modified on January 22, 2002, under which the court stayed all the filed or pending asbestos actions against us and, upon filing and service on us, all future asbestos actions. No further proceedings involving us can occur in the actions that have been stayed except upon further order of the Bankruptcy Court.

Committees appointed to represent asbestos claimants in Grace's bankruptcy case received the court's permission to pursue fraudulent transfer and other claims against the Company and its subsidiary Cryovac, Inc., and against Fresenius, as discussed below. The claims against Fresenius are based upon a 1996 transaction between Fresenius and W. R. Grace & Co.—Conn. Fresenius is not affiliated with us. In March 2002, the court ordered that the issues of the solvency of Grace following the Cryovac transaction and whether Grace received reasonably equivalent value in the Cryovac transaction would be tried on behalf of all of Grace's creditors. This proceeding was brought in the U.S. District Court for the District of Delaware (Adv. No. 02-02210).

In June 2002, the court permitted the U.S. government to intervene as a plaintiff in the fraudulent transfer proceeding, so that the U.S. government could pursue allegations that environmental remediation expenses were underestimated or omitted in the solvency analyses of Grace conducted at the time of the Cryovac transaction. The court also permitted Grace, which asserted that the Cryovac transaction was not a fraudulent transfer, to intervene in the proceeding. In July 2002, the court issued an interim ruling on the legal standards to be applied in the trial, holding, among other things, that, subject to specified limitations, post-1998 claims should be considered in the solvency analysis of Grace. We believe that only claims and liabilities that were known, or reasonably should have been known, at the time of the 1998 Cryovac transaction should be considered under the applicable standard.

With the fraudulent transfer trial set to commence on December 9, 2002, on November 27, 2002, we reached an agreement in principle with the Committees prosecuting the claims against the Company and Cryovac, Inc., to resolve all current and future asbestos-related claims arising from the Cryovac transaction. On the same day, the court entered an order confirming that the parties had reached an amicable resolution of the disputes among the parties and that counsel for us and the Committees had agreed and bound the parties to the terms of the agreement in principle. As discussed above, the agreement in principle called for payment of nine million shares of our common stock and $512.5 million in cash, plus interest on the cash payment at a 5.5% annual rate starting on December 21, 2002 and ending on the effective date of an appropriate plan of reorganization in the Grace bankruptcy, when we are required to make the payment. These shares are subject to customary anti-dilution provisions that adjust for the effects of stock splits, stock dividends and other events affecting our common stock, and as a result, the number of shares of our common stock that we will issue increased to eighteen million shares upon the two-for-one stock split in March 2007. On December 3, 2002, the Company's Board of Directors approved the agreement in principle. We received notice that both of the Committees had approved the agreement in principle as of December 5, 2002. The parties subsequently signed the definitive Settlement agreement as of November 10, 2003 consistent with the terms of the agreement in principle. On November 26, 2003, the parties jointly presented the definitive Settlement agreement to the U.S. District Court for the District of Delaware for approval. On Grace's motion to the U.S. District Court, that court transferred the motion to approve the Settlement agreement to the Bankruptcy Court for disposition.

On June 27, 2005, the Bankruptcy Court signed an order approving the Settlement agreement. Although Grace is not a party to the Settlement agreement, under the terms of the order, Grace is directed to comply with the Settlement agreement subject to limited exceptions. The order also provides that the Court will retain jurisdiction over any dispute involving the interpretation or enforcement of the terms and provisions of the Settlement agreement. We expect that the Settlement agreement will become effective upon Grace's emergence from bankruptcy pursuant to a plan of reorganization that is consistent with the terms of the Settlement agreement.

On June 8, 2004, we filed a motion with the U.S. District Court for the District of Delaware, where the fraudulent transfer trial was pending, requesting that the court vacate the July 2002 interim ruling on the legal standards to be applied relating to the fraudulent transfer claims against us. We were not challenging the Settlement agreement. The motion was filed as a protective measure in the event that the Settlement agreement is ultimately not approved or implemented; however, we still expect that the Settlement agreement will become effective upon Grace's emergence from bankruptcy with a plan of reorganization that is consistent with the terms of the Settlement agreement.

On July 11, 2005, the Bankruptcy Court entered an order closing the proceeding brought in 2002 by the committees appointed to represent asbestos claimants in the Grace bankruptcy proceeding against us without prejudice to our right to reopen the matter and renew in our sole discretion our motion to vacate the July 2002 interim ruling on the legal standards to be applied relating to the fraudulent transfer claims against us.

As a condition to our obligation to make the payments required by the Settlement agreement, any final plan of reorganization must be consistent with the terms of the Settlement agreement, including provisions for the trusts and releases referred to below and for an injunction barring the prosecution of any asbestos-related claims against us. The Settlement agreement provides that, upon the effective date of the final plan of reorganization and payment of the shares and cash, all present and future asbestos-related claims against us that arise from alleged asbestos liabilities of Grace and its affiliates (including former affiliates that became our affiliates through the Cryovac transaction) will be channeled to and become the responsibility of one or more trusts to be established under Section 524(g) of the Bankruptcy Code as part of a final plan of reorganization in the Grace bankruptcy. The Settlement agreement will also resolve all fraudulent transfer claims against us arising from the Cryovac transaction as well as the Fresenius claims described below. The Settlement agreement provides that we will receive releases of all those claims upon payment. Under the agreement, we cannot seek indemnity from Grace for our payments required by the Settlement agreement. The order approving the Settlement agreement also provides that the stay of proceedings involving us described above will continue through the effective date of the final plan of reorganization, after which, upon implementation of the Settlement agreement, we will be released from the liabilities asserted in those proceedings and their continued prosecution against us will be enjoined.

In January 2005, Grace filed a proposed plan of reorganization (the "Grace Plan") with the Bankruptcy Court. There were a number of objections filed. The Official Committee of Asbestos Personal Injury Claimants (the "ACC") and the Asbestos PI Future Claimants' Representative (the "FCR") filed their proposed plan of reorganization (the "Claimants' Plan") with the Bankruptcy Court

in November 2007. On April 7, 2008, Grace issued a press release announcing that Grace, the ACC, the FCR, and the Official Committee of Equity Security Holders (the "Equity Committee") had reached an agreement in principle to settle all present and future asbestos-related personal injury claims against Grace (the "PI Settlement") and disclosed a term sheet outlining certain terms of the PI Settlement and for a contemplated plan of reorganization that would incorporate the PI Settlement (as filed and amended from time to time, the "PI Settlement Plan").

On September 19, 2008, Grace, the ACC, the FCR, and the Equity Committee filed, as co-proponents, the PI Settlement Plan and several exhibits and associated documents, including a disclosure statement (as filed and amended from time to time, the "PI Settlement Disclosure Statement"), with the Bankruptcy Court. Amended versions of the PI Settlement Plan and the PI Settlement Disclosure Statement have been filed with the Bankruptcy Court from time to time. The PI Settlement Plan, which supersedes each of the Grace Plan and the Claimants' Plan, remains pending before the Bankruptcy Court. The committee representing general unsecured creditors and the Official Committee of Asbestos Property Damage Claimants are not co-proponents of the PI Settlement Plan. As filed, the PI Settlement Plan would provide for the establishment of two asbestos trusts under Section 524(g) of the United States Bankruptcy Code to which present and future asbestos-related claims would be channeled. The PI Settlement Plan also contemplates that the terms of the Settlement agreement will be incorporated into the PI Settlement Plan and that we will pay the amount contemplated by the Settlement agreement. On March 9, 2009, the Bankruptcy Court entered an order approving the PI Settlement Disclosure Statement (the "DS Order") as containing adequate information and authorizing Grace to solicit votes to accept or reject the PI Settlement Plan, all as more fully described in the order. The DS Order does not constitute the Bankruptcy Court's confirmation of the PI Settlement Plan, approval of the merits of the PI Settlement Plan, or endorsement of the PI Settlement Plan. In connection with the plan voting process in the Grace bankruptcy case, we have voted in favor of the PI Settlement Plan that is currently before the Bankruptcy Court. We will continue to review any amendments to the PI Settlement Plan on an ongoing basis to verify compliance with the Settlement agreement.

On June 8, 2009, a senior manager with the voting agent appointed in the Grace bankruptcy case filed a declaration with the Bankruptcy Court certifying the voting results with respect to the PI Settlement Plan. This declaration was amended on August 5, 2009 (as amended, the "Voting Declaration"). According to the Voting Declaration, with respect to each class of claims designated as impaired by Grace, the PI Settlement Plan has been approved by holders of at least two-thirds in amount and more than one-half in number (or for classes voting for purposes of Section 524(g) of the Bankruptcy Code, at least 75% in number) of voted claims. The Voting Declaration also discusses the voting results with respect to holders of general unsecured claims ("GUCs") against Grace, whose votes have been provisionally solicited and counted subject to a determination by the Bankruptcy Court of whether GUCs are impaired (and, thus, entitled to vote) or, as Grace contends, unimpaired (and, thus, not entitled to vote). The Voting Declaration provides that more than one half of voting holders of GUCs have voted to accept the PI Settlement Plan, but that the provisional vote has not obtained the requisite two-thirds dollar amount to be deemed an accepting class in the event that GUCs are determined to be impaired. The Bankruptcy Court has yet to determine whether GUCs are impaired under the PI Settlement Plan. To the extent that GUCs are determined to be an impaired

non-accepting class, Grace and the other plan proponents have indicated that they will nevertheless seek confirmation of the PI Settlement Plan under the "cram down" provisions contained in section 1129(b) of the Bankruptcy Code.

Although we are optimistic that, if confirmed, the PI Settlement Plan would implement the terms of the Settlement agreement, we can give no assurance that this will be the case. The terms of the PI Settlement Plan remain subject to amendment. Moreover, the PI Settlement Plan is subject to the satisfaction of a number of conditions, including the availability of exit financing and the approval of both the Bankruptcy Court and United States District Court for the District of Delaware (the "District Court"). Parties have filed a number of objections to the PI Settlement Plan, some of which remain unresolved, and some of these objections concern injunctions, releases and provisions as applied to us and/or that are contemplated by the Settlement agreement.

The Bankruptcy Court has conducted hearings to consider confirmation of the PI Settlement Plan and has heard closing arguments with respect to the PI Settlement Plan, but additional hearings may be held by the Bankruptcy Court and the District Court to consider matters related to the PI Settlement Plan. Grace, the ACC, the FCR, and the Equity Committee have filed, as co-proponents, a proposed confirmation order with respect to the PI Settlement Plan. However, the Bankruptcy Court has not indicated whether it will confirm the PI Settlement Plan and, as indicated above, objections to the PI Settlement Plan remain pending (including objections relating to injunctions, releases and provisions as applied to us and/or that are contemplated by the Settlement agreement). We do not know whether or when a final plan of reorganization will be confirmed or become effective. Assuming that a final plan of reorganization (whether the PI Settlement Plan or another plan of reorganization) is confirmed by the Bankruptcy Court, approved by the District Court, and does become effective, we do not know whether the final plan of reorganization will be consistent with the terms of the Settlement agreement or if the other conditions to our obligation to pay the Settlement agreement amount will be met. If these conditions are not satisfied or not waived by us, we will not be obligated to pay the amount contemplated by the Settlement agreement. However, if we do not pay the Settlement agreement amount, we will not be released from the various asbestos-related, fraudulent transfer, successor liability, and indemnification claims made against us and all of these claims would remain pending and would have to be resolved through other means, such as through agreement on alternative settlement terms or trials. In that case, we could face liabilities that are significantly different from our obligations under the Settlement agreement. We cannot estimate at this time what those differences or their magnitude may be. In the event these liabilities are materially larger than the current existing obligations, they could have a material adverse effect on our consolidated financial position and results of operations.

In January 2002, we filed a declaratory judgment action against Fresenius Medical Care Holdings, Inc., its parent, Fresenius AG, a German company, and specified affiliates in New York State court asking the court to resolve a contract dispute between the parties. The Fresenius parties contended that we were obligated to indemnify them for liabilities that they might incur as a result of the 1996 Fresenius transaction mentioned above. The Fresenius parties' contention was based on their

interpretation of the agreements between them and W. R. Grace & Co.—Conn. in connection with the 1996 Fresenius transaction. In February 2002, the Fresenius parties announced that they had accrued a charge of $172.0 million for these potential liabilities, which included pre-transaction tax liabilities of Grace and the costs of defense of litigation arising from Grace's Chapter 11 filing. We believe that we were not responsible to indemnify the Fresenius parties under the 1996 agreements and filed the action to proceed to a resolution of the Fresenius parties' claims. In April 2002, the Fresenius parties filed a motion to dismiss the action and for entry of declaratory relief in its favor. We opposed the motion, and in July 2003, the court denied the motion without prejudice in view of the November 27, 2002 agreement in principle referred to above. As noted above, under the Settlement agreement, we and the Fresenius parties will exchange mutual releases, which will release us from any and all claims related to the 1996 Fresenius transaction.

In November 2004, the Company's Canadian subsidiary Sealed Air (Canada) Co./Cie learned that it had been named a defendant in the case of Thundersky v. The Attorney General of Canada, et al. (File No. CI04-01-39818), pending in the Manitoba Court of Queen's Bench. Grace and W. R. Grace & Co.—Conn. are also named as defendants. The plaintiff brought the claim as a putative class proceeding and seeks recovery for alleged injuries suffered by any Canadian resident, other than in the course of employment, as a result of Grace's marketing, selling, processing, manufacturing, distributing and/or delivering asbestos or asbestos-containing products in Canada prior to the Cryovac Transaction. A plaintiff filed another proceeding in January 2005 in the Manitoba Court of The Queen's Bench naming the Company and specified subsidiaries as defendants. The latter proceeding, Her Majesty the Queen in Right of the Province of Manitoba v. The Attorney General of Canada, et al. (File No. CI05-01-41069), seeks the recovery of the cost of insured health services allegedly provided by the Government of Manitoba to the members of the class of plaintiffs in the Thundersky proceeding. In October 2005, we learned that six additional putative class proceedings had been brought in various provincial and federal courts in Canada seeking recovery from the Company and its subsidiaries Cryovac, Inc. and Sealed Air (Canada) Co./Cie, as well as other defendants including W. R. Grace & Co. and W. R. Grace & Co.—Conn., for alleged injuries suffered by any Canadian resident, other than in the course of employment (except with respect to one of these six claims), as a result of Grace's marketing, selling, manufacturing, processing, distributing and/or delivering asbestos or asbestos-containing products in Canada prior to the Cryovac transaction. Grace and W. R. Grace & Co.—Conn. have agreed to defend, indemnify and hold harmless the Company and its affiliates in respect of any liability and expense, including legal fees and costs, in these actions.

In April 2001, Grace Canada, Inc. had obtained an order of the Superior Court of Justice, Commercial List, Toronto (the "Canadian Court"), recognizing the Chapter 11 actions in the United States of America involving Grace Canada, Inc.'s U.S. parent corporation and other affiliates of Grace Canada, Inc., and enjoining all new actions and staying all current proceedings against Grace Canada, Inc. related to asbestos under the Companies' Creditors Arrangement Act. That order has been renewed repeatedly. In November 2005, upon motion by Grace Canada, Inc., the Canadian Court ordered an extension of the injunction and stay to actions involving asbestos against the Company and its Canadian affiliate and the Attorney General of Canada, which had the effect of staying all of the

Canadian actions referred to above. The parties finalized a global settlement of these Canadian actions (except for claims against the Canadian government). That settlement, which has subsequently been amended (the "Canadian Settlement") will be entirely funded by Grace. The Canadian Court issued an Order on December 13, 2009 approving the Canadian Settlement. We do not have any positive obligations under the Canadian Settlement, but we are a beneficiary of the release of claims. The release in favor of the Grace parties (including us) will become operative upon the effective date of a plan of reorganization in Grace's United States Chapter 11 bankruptcy proceeding. As filed, the PI Settlement Plan contemplates that the claims released under the Canadian Settlement will be subject to injunctions under Section 524(g) of the Bankruptcy Code. By its terms, the Canadian Settlement will, unless amended, become null and void if a confirmation order in the Grace U.S. bankruptcy proceeding is not granted prior to December 31, 2010. We can give no assurance that the PI Settlement Plan (or any other plan of reorganization) will be confirmed by the Bankruptcy Court, approved by the District Court, or will become effective. Assuming that a final plan of reorganization (whether the PI Settlement Plan or another plan of reorganization) is confirmed by the Bankruptcy Court, approved by the District Court, and does become effective, if the final plan of reorganization does not incorporate the terms of the Canadian Settlement or if the Canadian courts refuse to enforce the final plan of reorganization in the Canadian courts, and if in addition Grace is unwilling or unable to defend and indemnify the Company and its subsidiaries in these cases, then we could be required to pay substantial damages, which we cannot estimate at this time and which could have a material adverse effect on our consolidated financial position and results of operations.

In view of Grace's Chapter 11 filing, we may receive additional claims asserting that we are liable for obligations that Grace had agreed to retain in the Cryovac transaction and for which we may be contingently liable. To date, we are not aware of any material claims having been asserted or threatened against us.

Final determinations and accountings under the Cryovac transaction agreements with respect to matters pertaining to the transaction had not been completed at the time of Grace's Chapter 11 filing in 2001. We have filed claims in the bankruptcy proceeding that reflect the costs and liabilities that we have incurred or may incur that Grace and its affiliates agreed to retain or that are subject to indemnification by Grace and its affiliates under the Cryovac transaction agreements, other than payments to be made under the Settlement agreement. Grace has alleged that we are responsible for specified amounts under the Cryovac transaction agreements. Subject to the terms of the Settlement agreement, amounts for which we may be liable to Grace may be used to offset the liabilities of Grace and its affiliates to us. We intend to seek indemnification by Grace and its affiliates for defense costs related to asbestos and fraudulent transfer litigation and the Fresenius claims, and approximately $8.1 million paid by us on account of our guaranty of debt issued by W. R. Grace & Co.—Conn. Except to the extent of any potential setoff or similar claim, we expect that our claims will be as an unsecured creditor of Grace. Since portions of our claims against Grace and its affiliates are contingent or unliquidated, we cannot determine the amount of our claims, the extent to which these claims may be reduced by setoff, how much of the claims may be allowed, or the amount of our recovery on these claims, if any, in the bankruptcy proceeding.

On October 14, 2010, our Board of Directors declared a quarterly cash dividend of $0.13 per common share. This dividend is payable on December 17, 2010 to stockholders of record at the close of business on December 3, 2010. The estimated amount of this dividend payment is $21 million based on 160 million shares of our common stock issued and outstanding as of October 31, 2010.

On July 27, 2010, our Board of Directors increased the quarterly dividend by 8% to $0.13 per common share from $0.12 per common share. During the first nine months of 2010, we declared and paid quarterly cash dividends on March 19, 2010 to stockholders of record at the close of business on March 5, 2010, on June 18, 2010 to stockholders of record on June 4, 2010 and on September 17, 2010 to stockholders of record on September 3, 2010. We used available cash totaling $59.0 million to pay these quarterly cash dividends.

The dividend payments discussed above are recorded as reductions to retained earnings on our condensed consolidated balance sheets. From time to time, we may consider other means of returning value to our stockholders based on our consolidated financial position and results of operations. There is no guarantee that our Board of Directors will declare any further dividends.

We record share-based compensation expense in marketing, administrative and development expenses on our condensed consolidated statements of operations with a corresponding credit to additional paid-in capital within stockholders' equity based on the fair value of share-based compensation awards at the date of grant. Each quarter, we recognize an expense or credit reflecting the straight-line recognition of the expected cost of the program. For the 2010 three-year PSU awards and the 2009 two-year and three-year PSU awards, to the extent the performance against the targets improves or worsens, the cumulative amount accrued to date is adjusted up or down.

Total share-based compensation expense by program in the 2010 and 2009 periods was as follows:

As of September 30, 2010, the estimated amount of total share-based compensation expense expected to be recognized on a straight-line basis over the remaining respective vesting periods by program was as follows:

For the 2010 Three-year PSU awards and the 2009 Two-year and Three-year awards, the estimated amount of this future share-based compensation expense will fluctuate based on: 1) the level of achievement of the respective goals and measures considered probable in future quarters, which impacts the number of shares that could be issued; and 2) the future price of our common stock, which impacts the expense related to additional discretionary shares.

The discussion that follows provides further details of our share-based compensation programs.

As part of our long term incentive program adopted in 2008, during the first 90 days of each year starting in 2008, the Organization and Compensation Committee of our Board of Directors, or Compensation Committee, has approved Performance Share Unit (PSU) awards for our executive officers and other selected key executives, which includes for each officer or executive a target number of shares of common stock and performance goals and measures that will determine the percentage of the target award that is earned following the end of the performance period. Following the end of the performance period, participants will also receive a cash payment in the amount of the dividends (without interest) that would have been paid during the performance period on the number of shares that they have earned.

In March 2010, the Compensation Committee approved awards with a three-year performance period beginning January 1, 2010. The Compensation Committee established principal performance goals, which are 1) three-year cumulative volume growth of net trade sales and 2) three-year average return on invested capital. These performance goals are outlined in further detail in the Proxy Statement for our 2010 Annual Meeting of Stockholders. The targeted number of shares of common stock that can be earned is 433,481 shares for these 2010 PSU awards. If the threshold level is achieved for either of the two performance goals mentioned above, then the number of shares earned for each participant can be increased (if the additional goal mentioned below is achieved) or decreased (if the additional goal mentioned below is not achieved) by up to 10% of the target level at the discretion of the Compensation Committee, or an aggregate of 43,348 shares for all participants. The additional goal

is a 2012 safety result of a total recordable incident rate (a workplace safety indicator) of 1.20 or better, excluding facilities acquired during the performance period.

The total number of shares to be issued for these awards can range from zero to 200% of the target number of shares depending on the level of achievement of the performance goals and measures, plus or minus the 43,348 additional discretionary shares mentioned above.

The expense included in the table above was calculated based on management's estimate as of September 30, 2010 of the level of probable achievement of the performance goals and measures, which was determined to be at the target level as of September 30, 2010.

The targeted number of shares of common stock that can be earned is 575,661 shares for the two-year PSU awards and 570,160 for the three-year PSU awards made in 2009. The total number of shares to be issued for each PSU for the two-year awards and the three-year awards can range from zero to 200% of the target number of shares depending on the level of achievement of the operating performance goals and measures. If the threshold level is achieved for the operating performance goals and measures, then the number of shares earned for each participant can be increased (if the additional goals mentioned below are achieved) or decreased (if the additional goals mentioned below are not achieved) by up to 10% of the target level at the discretion of the Compensation Committee, or an aggregate of 114,582 shares for all participants for both awards. The additional goals are 1) average quarterly inventory days on hand starting December 31, 2008 through the performance period below the average quarterly days on hand for the period December 31, 2007 through December 31, 2008; and 2) a safety result for the final year of the performance period of a total recordable incident rate of 1.30 or better, excluding facilities acquired during the performance period. These provisions are outlined in further detail in the Proxy Statement for our Annual Meeting of Stockholders. Probable achievement of the operating performance goals and measures based on management's estimate as of September 30, 2010 was determined to be at the maximum level for both the two-year PSU awards (1,151,322 shares) and the three-year PSU awards (1,140,320 shares) as of September 30, 2010. Probable achievement of the operating performance goals and measures based on management's estimate as of September 30, 2009 was determined to be at the target level for both the two-year PSU awards (701,962 shares) and the three-year PSU awards (701,962 shares) as of September 30, 2009. Both the two-year and three-year awards are net of forfeitures in 2010 and 2009.

Under our executive compensation program, the Compensation Committee may grant our executive officers and a small number of other key executives stock leverage opportunity awards, known as SLO awards, as part of our annual incentive plan. The SLO awards are described in further detail in our Proxy Statement for our 2010 Annual Meeting of Stockholders. Other employees are eligible to receive awards of restricted stock, restricted stock units and cash awards as long-term share-based incentive compensation under our 2005 Contingent Stock Plan. Our executive officers and other key executives may also receive awards of restricted stock or restricted stock units from time to time.

The following table sets forth the calculation of basic and diluted net earnings per common share under the two-class method for the three and nine months ended September 30, 2010 and 2009.

			Three Months Ended September 30,						Nine Months Ended September 30,

			2010			2009			2010			2009
*Basic Net Earnings Per Common Share:*
Numerator
	Net earnings available to common stockholders		$	76.5		$	60.6		$	204.6		$	179.2
	Distributed and allocated undistributed net earnings to non-vested restricted stockholders			(0.4	)		(0.5	)		(1.3	)		(1.4	)

Distributed and allocated undistributed net earnings to common stockholders				76.1			60.1			203.3			177.8
	Distributed net earnings—dividends paid to common stockholders			(20.6	)		(18.9	)		(58.6	)		(56.6	)

Allocation of undistributed net earnings to common stockholders			$	55.5		$	41.2		$	144.7		$	121.2

Denominator
	Weighted average number of common shares outstanding—basic			158.3			157.4			158.2			157.1

Basic net earnings per common share:
	Distributed net earnings to common stockholders		$	0.13		$	0.12		$	0.37		$	0.36
	Allocated undistributed net earnings to common stockholders			0.35			0.26			0.92			0.77

Basic net earnings per common share:			$	0.48		$	0.38		$	1.29		$	1.13

*Diluted Net Earnings Per Common Share:*
Numerator
	Distributed and allocated undistributed net earnings to common stockholders		$	76.1		$	60.1		$	203.3		$	177.8
	Add: Allocated undistributed net earnings to non-vested restricted stockholders			0.4			0.4			1.0			1.0
		Interest on 3% Convertible Senior Notes, net of taxes(1)		—			0.4			—			4.4
	Less: Undistributed net earnings reallocated to non-vested restricted stockholders			(0.3	)		(0.3	)		(0.9	)		(0.9	)

Net earnings available to common stockholders—diluted			$	76.2		$	60.6		$	203.4		$	182.3

Denominator
Weighted average number of common shares outstanding—basic				158.3			157.4			158.2			157.1
		Effect of assumed issuance of Settlement agreement shares		18.0			18.0			18.0			18.0
		Effect of non-vested restricted stock and restricted stock units		0.4			0.2			0.2			0.2
		Effect of conversion of 3% Convertible Senior Notes(1)		—			2.7			—			9.6

	Weighted average number of common shares outstanding—diluted			176.7			178.3			176.4			184.9

Diluted net earnings per common share			$	0.43		$	0.34		$	1.15		$	0.99

Diluted weighted average number of common shares outstanding provides for the following items if their inclusion is dilutive: (1) the effect of assumed issuance of 18 million shares of common stock

reserved for the Settlement agreement in 2010 and 2009, (2) the effect of non-vested restricted stock and restricted stock units using the treasury stock method in 2010 and 2009 and (3) the effect of conversion of our then-outstanding 3% Convertible Senior Notes due June 2033 in July 2009.

Under U.S. GAAP, since the PSU awards discussed in Note 15, "Stockholders' Equity," are contingently issuable shares that are based on operating performance goals and measures, approximately 0.2 million shares of the 2009 Two-year PSU awards were included in the diluted weighted average number of common shares outstanding calculation for the three and nine months ended September 30, 2010 as the threshold for the operating performance goals and measures was met as of September 30, 2010. All other remaining shares related to the 2009 Two-year PSU awards and all of the shares related to the 2009 Three-year PSU awards and the 2010 Three-year PSU awards have been excluded from the diluted weighted average number of common shares outstanding for calculation of diluted net earnings per common share for the three and nine months ended September 30, 2010 because they have not met their respective performance conditions as of September 30, 2010.

The shares or units associated with the SLO awards for the fiscal year 2010 are considered contingent shares and therefore are not included in the basic or diluted weighted average number of common shares outstanding for the three and nine months ended September 30, 2010. These shares or units, discussed in Note 15, "Stockholders' Equity," will not be included in the common shares outstanding until the final determination of the amount of annual incentive compensation is made in the first quarter of the following year consistent with the treatment of these awards in 2009. Once this determination is made, the shares or units will be included in basic weighted average number of common shares outstanding if the employee is retirement eligible or in the diluted weighted average number of common shares outstanding if the employee is not retirement eligible.

Net foreign exchange transaction losses include the impact of changes in value associated with amounts receivable or payable on transactions denominated in foreign currencies and amounts related to certain foreign currency denominated receivables and payables and interest-bearing intercompany loans. We enter into foreign currency forward contracts to manage the potential changes in value associated with these transactions and intercompany items mentioned above, and the amounts included above are net of any gains or losses resulting from our foreign currency forward contracts. See Note 11, "Derivatives and Hedging Activities," for further discussion of our foreign currency forward contracts.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

The information in our Management's Discussion and Analysis of Financial Condition and Results of Operations should be read together with our condensed consolidated financial statements and related notes set forth in Item 1 of Part I of this quarterly report on Form 10-Q, Management's Discussion and Analysis of Financial Condition and Results of Operations set forth in Item 7 of Part II of our Annual Report on Form 10-K for the fiscal year ended December 31, 2009, and our consolidated financial statements and related notes set forth in Item 8 of Part II of that Form 10-K. See Part II, Item 1A, "Risk Factors" and "Cautionary Notice Regarding Forward-Looking Statements," below, and the information referenced therein, for a description of risks that we face and important factors that we believe could cause actual results to differ materially from those in our forward-looking statements. All amounts and percentages are approximate due to rounding and all dollars are in millions. When we cross-reference to a "Note," we are referring to our "Notes to Condensed Consolidated Financial Statements," unless the context indicates otherwise.

In our Management's Discussion and Analysis of Financial Condition and Results of Operations, we present financial information in accordance with U.S. GAAP, but we also present financial measures that do not conform to U.S. GAAP, which we refer to as non-U.S. GAAP. As discussed below, we provide this supplemental information as our management believes it is useful to investors. Investors should use caution, however, when reviewing our non-U.S. GAAP presentations. The non-U.S. GAAP information is not a substitute for U.S. GAAP information. It does not purport to represent the similarly titled U.S. GAAP information and is not an indicator of our performance under U.S. GAAP. Further, non-U.S. GAAP financial measures that we present may not be comparable with similarly titled measures used by others.

In our "2010 Outlook" below, we present anticipated full year 2010 diluted net earnings per common share on a U.S. GAAP basis, but also on a non-U.S. GAAP adjusted basis—excluding an estimated $0.02 charge related to GMS and non-operating gains or losses that may be recognized in 2010 related to currency fluctuations in Venezuela as we believe these gains or losses are attributable to the significant foreign exchange fluctuations in that country. We will exclude future foreign exchange and other non-operating gains and or losses from our non-U.S. GAAP adjusted diluted earnings per common share relating to our Venezuelan subsidiary until such time that we believe the foreign exchange environment in Venezuela stabilizes. Our full year 2010 guidance also excludes the payment of the Settlement agreement, as the timing of such payment is unknown.

We believe that excluding these items from our projected earnings aids in the comparison of our earnings performance between 2010 and prior years. We also present adjusted diluted net earnings per common share in our "Highlights of Financial Performance" below, for our 2010 and 2009 results. Our management will look at our earnings performance both on an U.S. GAAP basis and a non-U.S. GAAP basis. Further, the items excluded from non-U.S. GAAP adjusted basis may also be excluded from the calculations of our performance measures set by the Organization and Compensation Committee of our Board of Directors for purposes of determining incentive compensation. Thus, our management believes that this information may be useful to investors.

In our "Highlights of Financial Performance," "Net Sales by Segment Reporting Structure" and "Net Sales by Geographic Region" below, we first present our results in accordance with U.S. GAAP and then present a Non-U.S. GAAP financial measure "adjusted diluted net earnings per common share." Also, in some of the discussions and tables that follow, we exclude the impact of foreign currency translation when presenting net sales information. Changes in net sales excluding the impact of foreign currency translation is a non-U.S. GAAP financial measure, which we define as "constant dollar." As a worldwide business, it is important that we take into account the effects of foreign

currency translation when we view our results and plan our strategies. Nonetheless, we cannot directly control changes in foreign currency exchange rates. Consequently, when our management looks at net sales to measure the performance of our business, it typically excludes the impact of foreign currency translation from net sales. We also may exclude the impact of foreign currency translation when making incentive compensation determinations. As a result, our management believes that these presentations may be useful to investors.

Our current outlook anticipates that our constant dollar sales growth rate will accelerate sequentially in the fourth quarter of 2010 from a combination of unit volume growth and favorable product price/mix. This growth assumes continuing improvement in global economic conditions, ongoing strength in our industrial businesses (which includes our Protective Packaging segment and Specialty Materials business) and a mid-single digit constant dollar sales growth rate in our food businesses. This increased rate of sales growth in our food businesses reflects the combination of increased food customer production rates, new contracts and the continued benefits of pricing actions and contract adjustments expected in the fourth quarter. We expect all of our businesses to continue to benefit from the successful launches and adoptions of new solutions and technologies and from growth in developing regions. We now expect to be in the lower end of our range of 4% to 6% growth in total constant dollar sales for full year 2010 as compared with 2009.

In the first nine months of 2010, our net sales benefited from a $78 million, or 2.5%, net favorable impact from foreign currency translation. On a full year over year basis, we expect an approximate 2% benefit on our net sales from foreign currency translation. We anticipate that a year over year unfavorable translational effect of the euro will be offset by a favorable effect from other currencies relative to the U.S. dollar.

Our average petrochemical-based raw material costs, primarily resin costs, reached their highest level on a year over year comparison in the month of April 2010. Our current outlook assumes moderating resin costs for the fourth quarter of 2010 resulting in a low double-digit percentage increase in the average cost of resin for 2010 as compared with 2009. In the fourth quarter of 2010, we expect to realize additional benefits from our pricing actions that targeted resin cost recovery as well as favorable formula pricing adjustments in our food businesses.

We anticipate marketing, administrative and development expenses to be approximately 16% of net sales and capital expenditures to be in the range of $80 to $90 million. Depreciation and amortization expense is now expected to be approximately $185 million. This amount includes approximately $30 million of share-based compensation expense.

We have raised our effective income tax rate guidance for the full year 2010 to 28% from 27%. Our original guidance anticipated an extension of certain U.S. tax credits that expired at December 31, 2009. If the U.S. Congress passes and retroactively applies these tax credits, then we would expect to be in the upper end of our diluted net earnings per common share guidance range detailed below.

We have narrowed our full year 2010 diluted net earnings per common share guidance to $1.54 to $1.60, or $1.56 to $1.62 on an adjusted basis to exclude an estimated $0.02 charge for costs related to GMS. This guidance also excludes any non-operating gains or losses that may be recognized in 2010 related to currency fluctuations in Venezuela and the payment of the Settlement agreement, as the timing of such payment is unknown. Payment under the Settlement agreement is expected to be accretive to our post-payment diluted net earnings per common share by approximately $0.12 to $0.14 annually. See "Settlement Agreement and Related Costs," of "Material Commitments and Contingencies," for further discussion.

On July 27, 2010, our Board of Directors increased the quarterly dividend by 8% to $0.13 per common share from $0.12 per common share. During the first nine months of 2010, we declared and paid quarterly cash dividends in March, June and September. We used available cash totaling $59 million to pay these quarterly cash dividends.

Below are the highlights of our financial performance in the third quarter and first nine months of 2010 compared with the same periods of 2009:

		Third Quarter of									First Nine Months of

		Third Quarter of						% Change			First Nine Months of						% Change
		2010			2009			% Change			2010			2009			% Change
Net sales		$	1,130.0		$	1,079.9			5	%	$	3,280.9		$	3,096.4			6	%

Gross profit		$	320.5		$	311.1			3		$	921.0		$	884.9			4
	As a % of net sales		28.4	%		28.8	%					28.1	%		28.6	%
Marketing, administrative and development expenses			173.3			180.0			(4	)		520.4			515.5			1
	As a % of net sales		15.3	%		16.7	%					15.9	%		16.6	%
Restructuring and other charges			0.1			0.9			(89	)		0.4			1.2			(67	)

Operating profit		$	147.1		$	130.2			13		$	400.2		$	368.2			9

	As a % of net sales		13.0	%		12.1	%					12.2	%		11.9	%
Net earnings available to common stockholders		$	76.5		$	60.6			26	%	$	204.6		$	179.2			14	%

Net earnings per common share:
	Basic	$	0.48		$	0.38			26	%	$	1.29		$	1.13			14	%

	Diluted	$	0.43		$	0.34			26	%	$	1.15		$	0.99			16	%

Weighted average number of common shares outstanding:
	Basic		158.3			157.4						158.2			157.1

	Diluted		176.7			178.3						176.4			184.9

As shown in the table above, our net earnings per diluted common share increased 26% in the third quarter of 2010 compared with the same period in 2009.

The primary contributing factors to our net earnings growth in the third quarter compared with the same period of 2009 were:

These factors were partially offset by a higher third quarter effective tax rate in 2010 of 27.5% compared with 23.6% in 2009, which was mostly due to the utilization of some U.S. income tax credits in 2009 that expired in December 2009.

On an adjusted basis, excluding the items detailed in "Diluted Net Earnings per Common Share" below, our diluted net earnings per common share increased 13% to $0.43 in the third quarter of 2010 from $0.38 in the same period of 2009. We included a reconciliation of U.S. GAAP diluted net earnings per common share to non-U.S. GAAP adjusted diluted net earnings per common share in "Diluted Net Earnings per Common Share," below.

See the discussions below for further details about the material factors that contributed to the changes in our net earnings for the third quarter of 2010 and first nine months of 2010 compared with the same periods in 2009.

			Third Quarter of									First Nine Months of

			Third Quarter of						% Change			First Nine Months of						% Change
			2010			2009			% Change			2010			2009			% Change
Net sales:
	Food Packaging		$	483.4		$	463.4			4	%	$	1,390.0		$	1,336.1			4	%
		As a % of net sales		42.8	%		42.9	%					42.4	%		43.1	%
	Food Solutions			240.4			229.6			5			687.7			655.0			5
		As a % of net sales		21.3	%		21.3	%					20.9	%		21.2	%
	Protective Packaging			327.0			306.1			7			954.4			868.0			10
		As a % of net sales		28.9	%		28.3	%					29.1	%		28.0	%
	Other			79.2			80.8			(2	)		248.8			237.3			5
		As a % of net sales		7.0	%		7.5	%					7.6	%		7.7	%

Total			$	1,130.0		$	1,079.9			5	%	$	3,280.9		$	3,096.4			6	%

By geographic region, the components of the increase in net sales for the third quarter of 2010 and first nine months of 2010 compared with the same periods of 2009 were as follows:

As shown above, 52% of our third quarter 2010 consolidated net sales were generated outside the U.S. Approximately 20% of our consolidated net sales are euro-denominated. Due to global economic factors, including the on-going concerns about the ability of some countries in the euro zone to effectively manage sovereign debt obligations and concerns about rising budget deficits, in the first nine months of 2010 the euro has weakened against the U.S. dollar compared with the same period of 2009.

During the third quarter of 2010, our net sales results reflected an approximate 11% decline in the average euro to U.S. dollar exchange ratio as compared with the same period in 2009. This decline was partially offset by the strengthening of most of our other average foreign currency exchange ratios, most notably the Australian dollar, Canadian dollar and Brazilian real, which appreciated against the U.S dollar. As a result of the factors mentioned above, the aggregate unfavorable impact from foreign currency translation on our net sales was $10 million.

During the first nine months of 2010, the average euro to U.S. dollar exchange ratio declined approximately 3% compared with the same period in 2009, while most of our other average foreign currency exchange ratios including the Australian dollar, Canadian dollar and Brazilian real appreciated against the U.S. dollar. As a result of the factors mentioned above, the aggregate favorable impact from foreign currency translation on our net sales was $78 million.

The following tables present the components of change in net sales by our segment reporting structure for the third quarter of 2010 and first nine months of 2010 compared with the same periods in 2009. We also present the change in net sales excluding the impact of foreign currency translation, a

non-U.S. GAAP measure, which we define as "constant dollar." We believe using constant dollar measures aids in the comparability between periods.

Third Quarter of 2010		Food Packaging					Food Solutions					Protective Packaging					Other					Total Company

Volume—Units		$	15.6		3.4	%	$	7.0		3.0	%	$	27.7		9.0	%	$	0.5		0.6	%	$	50.8		4.7	%
Volume—Acquired businesses, net of (dispositions)			—		—			—		—			(1.7	)	(0.6	)		(0.4	)	(0.4	)		(2.1	)	(0.2	)
Product price/mix			3.1		0.7			8.0		3.5			(1.5	)	(0.5	)		1.9		2.3			11.5		1.1
Foreign currency translation			1.3		0.2			(4.2	)	(1.8	)		(3.6	)	(1.1	)		(3.6	)	(4.5	)		(10.1	)	(1.0	)

	Total change (U.S. GAAP)	$	20.0		4.3	%	$	10.8		4.7	%	$	20.9		6.8	%	$	(1.6	)	(2.0	)%	$	50.1		4.6	%

Impact of foreign currency translation			(1.3	)	(0.2	)		4.2		1.8			3.6		1.1			3.6		4.5			10.1		1.0

	Total constant dollar change (Non-U.S. GAAP)	$	18.7		4.1	%	$	15.0		6.5	%	$	24.5		7.9	%	$	2.0		2.5	%	$	60.2		5.6	%

First Nine Months of 2010		Food Packaging					Food Solutions					Protective Packaging					Other					Total Company

Volume—Units		$	32.4		2.4	%	$	12.0		1.8	%	$	82.6		9.5	%	$	12.1		5.1	%	$	139.1		4.5	%
Volume—Acquired businesses, net of (dispositions)			—		—			—		—			(1.7	)	(0.2	)		(1.8	)	(0.7	)		(3.5	)	(0.1	)
Product price/mix			(27.8	)	(2.1	)		4.6		0.7			(7.5	)	(0.9	)		2.0		0.8			(28.7	)	(0.9	)
Foreign currency translation			49.3		3.7			16.1		2.5			13.0		1.6			(0.8	)	(0.3	)		77.6		2.5

	Total change (U.S. GAAP)	$	53.9		4.0	%	$	32.7		5.0	%	$	86.4		10.0	%	$	11.5		4.9	%	$	184.5		6.0	%

Impact of foreign currency translation			(49.3	)	(3.7	)		(16.1	)	(2.5	)		(13.0	)	(1.6	)		0.8		0.3			(77.6	)	(2.5	)

	Total constant dollar change (Non-U.S. GAAP)	$	4.6		0.3	%	$	16.6		2.5	%	$	73.4		8.4	%	$	12.3		5.2	%	$	106.9		3.5	%

The $19 million, or 4%, constant dollar increase in net sales in the third quarter of 2010 compared with the same period of 2009 was primarily due to:

Based on industry projections, we expect our customers' beef production rates to further improve in the fourth quarter of 2010, including expectations for an increase in demand due to the holiday season. This trend combined with favorable product price/mix is expected to contribute to an estimated low-single digit percent constant dollar sales increase for the full year 2010 as compared with 2009.

The $5 million constant dollar increase in net sales in the first nine months of 2010 compared with the same period of 2009 was primarily due to:

These factors were partially offset by a decline in product price/mix, which was experienced in all regions through the first half of 2010, but especially in North America where we encountered a $17 million, or 3%, decline. This decline reflected the timing of some contract price adjustments and the unfavorable impact of lower first half 2010 average selling prices that were set to reflect more moderate 2009 resin costs.

The $15 million, or 7%, constant dollar increase in net sales in the third quarter of 2010 compared with the same period of 2009 was primarily due to:

We expect similar trends in the fourth quarter of 2010 compared with 2009. Improving retail conditions combined with benefits from additional targeted pricing actions are expected to generate a mid-single digit percent constant dollar sales increase for the full year 2010 as compared with 2009.

The $17 million, or 3%, constant dollar increase in net sales in the first nine months of 2010 compared with the same period of 2009 was primarily due to:

These factors were partially offset by a decline in product price/mix in Europe of $5 million, or 2%, primarily due to the timing of price adjustments for changes in resin costs experienced in the first half of 2010.

The $25 million, or 8%, constant dollar increase in net sales in the third quarter of 2010 compared with the same period of 2009 was primarily due to increases in unit volumes in North America of $16 million, or 9%, in Europe of $7 million, or 8%, and in Asia of $3 million, or 13%.

The increases in unit volumes in these regions were predominately due to improving economic conditions, reflecting a modest recovery in export markets and manufacturing sectors. Also contributing to the increase in unit volumes, but to a lesser extent, were sales to new and existing customers of our new Protective Packaging products in these regions.

We expect demand to continue to increase sequentially in the fourth quarter and we also expect to benefit from our ongoing pricing actions. Combined, we expect constant dollar sales to increase in the high-single digit percent range for the full year 2010 compared with 2009.

The $73 million, or 8%, constant dollar increase in net sales in the first nine months of 2010 compared with the same period of 2009 was primarily due to increases in unit volumes in North America of $45 million, or 9%, in Europe of $17 million, or 7%, and in Asia of $16 million, or 25%, due to the factors mentioned above.

The $2 million, or 3%, constant dollar increase in net sales in the third quarter of 2010 compared with the same period in 2009 was primarily due to:

The increases in unit volumes in our specialty materials business in North America and Europe were primarily due to improving economic conditions, reflecting a modest recovery in manufacturing sectors. The increase in unit volumes in our medical applications business in Europe was primarily due to higher demand for our products from new and existing customers.

Other net sales in the third quarter of 2010 compared with 2009 was unfavorably impacted by lower unit volumes in Asia of $6 million, or 58%, due to an April 2010 licensing expiration in China in our medical applications business. Late in the third quarter of 2010 we received approval to import, distribute and sell reformulated medical film and sales. As a result, we expect net sales in our medical applications business to return to more normal levels in the fourth quarter.

The $12 million, or 5%, constant dollar increase in net sales in the first nine months of 2010 compared with the same period of 2009 was primarily due to:

The increases in unit volumes described above were partially offset by $10 million, or 30%, lower unit volumes in Asia primarily due to pre-buying in China in the first quarter of 2010 ahead of an April 2010 licensing expiration in that country in our medical applications business.

Our primary input costs include resins, direct and indirect labor, other raw materials and energy-related costs (including transportation costs). We utilize petrochemical-based resins in the manufacture of many of our products. The costs for these raw materials are impacted by the rise and fall in crude oil and natural gas prices, since they serve as feedstocks utilized in the production of most resins. Resin costs have been particularly volatile in recent years as a result of changes in global demand for these resins and feedstocks, as well as supply disruptions for these feedstocks. Although changes in the prices of crude oil and natural gas are not perfect benchmarks, they are indicative of the variations in raw materials and other input costs we face. We continue to monitor changes in raw material and energy-

related costs as they occur and take pricing actions as appropriate to lessen the impact of cost increases when they occur.

In this cost of sales section and in the marketing, administrative and development expenses section below, when we refer to "variable incentive compensation" we are referring to our annual U.S. profit sharing contribution (in both sections) and our annual cash incentive compensation (in the marketing, administrative and development expenses section). Variable incentive compensation does not include our share-based compensation programs. Details about our share-based compensation programs are included in Note 15, "Stockholders' Equity."

The $41 million increase in cost of sales in the third quarter of 2010 compared with the same period in 2009 was primarily due to:

These factors were partially offset by a favorable impact of foreign currency translation of $7 million.

The $148 million increase in cost of sales in the first nine months of 2010 compared with the same period in 2009 was primarily due to:

The factors described above that drove the increases in cost of sales for the third quarter and first nine months of 2010 compared with 2009 were partially offset by our supply chain productivity improvements, including lower headcount in 2010 compared with 2009, and by the benefits of producing products in our new, low-cost facilities in developing regions.

Also partially offsetting the increase in cost of sales were lower provisions for variable incentive compensation expenses of $3 million in the third quarter of 2010 and $6 million in the first nine months of 2010 compared with the same periods in 2009. These lower provisions were a result of our financial performance as of September 30, 2010 indicating that we may not achieve some of our pre-established full year 2010 variable incentive compensation goals. Our 2009 pre-established goals for

variable incentive compensation were substantially on target at September 30, 2009 and, as a result, no reductions to incentive compensation expenses were made.

Marketing, administrative and development expenses for the 2010 and 2009 periods were as follows:

The $7 million decrease in marketing, administrative and development expenses in the third quarter of 2010 compared with the same period in 2009 was primarily due to:

The $5 million increase in marketing, administrative and development expenses in the first nine months of 2010 compared with the same period in 2009 was primarily due to:

These factors were partially offset by lower provisions for variable incentive compensation expenses of $23 million, as a result of our financial performance as of September 30, 2010 indicating that we may not achieve some of our pre-established full year 2010 goals for variable incentive compensation. Our 2009 pre-established goals for incentive compensation were substantially on target at September 30, 2009 and, as a result, no reductions to incentive compensation expenses were made.

Consistent with past practice, we evaluate our accrual for variable incentive compensation expenses every quarter. Since our variable incentive compensation reflects performance against our operating profit goal, these expenses could be higher in the fourth quarter of the year if we achieve our pre-established operating profit goal for the full year 2010.

As mentioned in "2010 Outlook" above, we expect marketing, administrative and development expenses to be approximately 16% of net sales for the full year, at the lower end of our guidance provided at the beginning of the year.

We announced our global manufacturing strategy program in 2006. The goals of this multi-year program were to realign our manufacturing footprint to expand capacity in growing markets, to further improve our operating efficiencies, and to implement new technologies more effectively. Additionally, we have been optimizing certain manufacturing platforms in North America and Europe into centers of excellence. By taking advantage of new technologies and streamlining production on a global scale, we have continued to enhance our profitable growth and our global leadership position and have produced meaningful benefits.

The GMS program was to be a three-year program with total projected capital expenditures and related costs to implement this program of approximately $220 million. Cumulative capital expenditures and related costs to implement GMS were $230 million through September 30, 2010. Substantially all of the difference between the projected amount and the actual amount of capital expenditures and related costs was due to foreign currency translation.

In 2009, we opened a new manufacturing facility in Duchnice, Poland. This facility along with our other new facilities in Qingpu, China and Monterrey, Mexico completed the construction phase related to this program.

Total costs related to this program, which were primarily recorded in cost of sales, were $0.5 million in the third quarter of 2010, $4.2 million in the first nine months of 2010, $2.6 million in the third quarter of 2009 and $8.4 million in the first nine months of 2009. We anticipate an additional $1 million of costs in the fourth quarter of 2010 related to completing our GMS program.

We estimate that we have realized approximately $25 million in benefits in 2008, which increased to $45 million in 2009, and we expect to realize an additional $10 million of benefits in 2010 bringing total estimated annual benefits to $55 million in 2010 and thereafter. These benefits are primarily realized in cost of sales, and the actual timing and amount of these benefits are subject to change due to a variety of factors.

As mentioned in "2010 Outlook" above, we anticipate a total of $4 million of pre-tax costs, or $0.02 per diluted common share for GMS in 2010. See Note 4, "Global Manufacturing Strategy and 2008 Cost Reduction and Productivity Program," for additional information on GMS.

In 2008, we implemented a cost reduction and productivity program. We estimate that we have achieved annual savings from this program of approximately $55.0 million beginning in 2009. The components of the restructuring accrual related to this program through September 30, 2010 and the accrual balance remaining on our condensed consolidated balance sheet at September 30, 2010 are included in the table below.

Management evaluates the performance of each reportable segment based on its operating profit. Operating profit by our segment reporting structure for the 2010 and 2009 periods was as follows:

											First Nine Months of

		Third Quarter of
		Third Quarter of						% Change									% Change
		2010			2009			% Change			2010			2009			% Change
Food Packaging		$	70.3		$	63.5			11	%	$	184.3		$	184.5			—	%
	As a % of Food Packaging net sales		14.5	%		13.7	%					13.3	%		13.8	%
Food Solutions			27.5			21.4			29			71.5			66.3			8
	As a % of Food Solutions net sales		11.4	%		9.3	%					10.4	%		10.1	%
Protective Packaging			46.7			41.4			13			131.5			108.1			22
	As a % of Protective Packaging net sales		14.3	%		13.5	%					13.8	%		12.5	%
Other			2.7			4.8			(44	)		13.3			10.5			27
	As a % of Other net sales		3.4	%		5.9	%					5.3	%		4.4	%

Total segments and other			147.2			131.1			12	%		400.6			369.4			8	%
	As a % of net sales		13.0	%		12.1	%					12.2	%		11.9	%
Restructuring and other charges(1)			0.1			0.9			(89	)		0.4			1.2			(67	)

Total operating profit		$	147.1		$	130.2			13	%	$	400.2		$	368.2			9	%

	As a % of net sales		13.0	%		12.1	%					12.2	%		11.9	%

The increase in operating profit in the third quarter of 2010 compared with the same period in 2009 was primarily due to the favorable impacts of the increase in unit volumes and product price/mix, both mentioned above. Also contributing to this segment's increase in operating profit were lower marketing, administrative and development expenses as a percentage of net sales, which include the impact of lower provisions for variable incentive compensation expenses mentioned above. These factors were partially offset by higher average petrochemical-based raw material expenditures of approximately $10 million.

This segment's operating profit remained flat in the first nine months of 2010 compared with the same period in 2009. This was primarily due to higher average petrochemical-based raw material expenditures of approximately $35 million and the unfavorable product price/mix, which reflected the delayed timing of contract pricing adjustments for resin costs, mentioned above. These factors fully offset the favorable impacts of the increase in unit volumes and lower marketing, administrative and development expenses as a percentage of net sales, which include the impact of lower provisions for variable incentive compensation expenses, mentioned above.

The increase in operating profit in the first nine months of 2010 compared with the same period in 2009 was primarily due to the favorable impacts of the increase in unit volumes and product price/mix, both mentioned above. Also contributing to this segment's increase in operating profit were lower marketing, administrative and development expenses as a percentage of net sales, which include the impact of lower provisions for variable incentive compensation expenses mentioned above. These factors were partially offset by higher average petrochemical-based raw material expenditures of approximately $25 million.

The increase in operating profit in the third quarter of 2010 compared with the same period in 2009 was primarily due to the favorable impact of the increase in unit volumes mentioned above. Also contributing to this segment's increase in operating profit were lower marketing, administrative and development expenses as a percentage of net sales, which include the impact of lower provisions for variable incentive compensation expenses mentioned above. These factors were partially offset by higher average petrochemical-based raw material expenditures of approximately $8 million.

The increase in operating profit in the first nine months of 2010 compared with the same period in 2009 was primarily due to the favorable impact of the increase in unit volumes mentioned above. Also contributing to this segment's increase in operating profit were lower marketing, administrative and development expenses as a percentage of net sales, which include the impact of lower provisions for variable incentive compensation expenses mentioned above. These factors were partially offset by higher average petrochemical-based raw material expenditures of approximately $30 million.

The decrease in operating profit in the third quarter of 2010 compared with the same period in 2009 was primarily due to the unfavorable impact of lower unit volumes in Asia due to pre-buying in China in the first quarter of 2010 mentioned above. Also contributing to the decrease in operating profit was higher average petrochemical-based raw material expenditures of approximately $2 million. These factors were partially offset by the favorable impacts of higher unit volume growth in other regions and product price/mix, both mentioned above.

The increase in operating profit in the first nine months of 2010 compared with the same period of 2009 was primarily due to the favorable impact from the increases in unit volumes mentioned above, partially offset by higher average petrochemical-based raw material expenditures of approximately $10 million.

Interest expense includes the stated interest rate on our outstanding debt, as well as the net impact of capitalized interest, the effects of interest rate swaps and the amortization of capitalized senior debt issuance costs, bond discounts, and terminated treasury locks. We expect to incur approximately $160 million of interest expense in 2010, which includes approximately $41 million of interest expense for a full year of accrued interest on the cash portion of the Settlement agreement.

		Third Quarter of									First Nine Months of

		Third Quarter of						2010 vs. 2009 Change			First Nine Months of						2010 vs. 2009 Change
		2010			2009			2010 vs. 2009 Change			2010			2009			2010 vs. 2009 Change
Interest expense on the amount payable for the Settlement agreement		$	10.3		$	9.7		$	0.6		$	30.8		$	29.2		$	1.6
Interest expense on our senior notes:
	5.625% Senior Notes due July 2013		5.4			5.4			—			16.4			16.4			—
	12% Senior Notes due February 2014		7.8			8.7			(0.9	)		23.7			23.1			0.6
	7.875% Senior Notes due June 2017, issued June 2009		8.3			8.2			0.1			24.8			9.3			15.5
	6.875% Senior Notes due July 2033		7.7			7.8			(0.1	)		23.2			23.2			—
	3% Convertible Senior Notes redeemed July 2009		—			0.8			(0.8	)		—			8.0			(8.0	)
	6.95% Senior Notes matured May 2009		—			—			—			—			3.6			(3.6	)
Other interest expense			1.8			2.4			(0.6	)		6.2			7.2			(1.0	)
Less: capitalized interest			(0.6	)		(1.1	)		0.5			(2.7	)		(5.4	)		2.7

Total		$	40.7		$	41.9		$	(1.2	)	$	122.4		$	114.6		$	7.8

Net Gains on Sale (Other-Than-Temporary Impairment) of Available-for-Sale Securities

At September 30, 2009, our valuation of some of our auction rate security investments resulted in the recognition of other-than-temporary impairment of $3 million, which was recorded in the third quarter of 2009.

The estimated fair value of our remaining auction rate security investment at September 30, 2010 was approximately $10 million. See Note 5, "Available-for-Sale Investments," for further discussion.

The foreign currency exchange gains and losses we recorded in 2010 for our Venezuelan subsidiary were the result of two factors: 1) the significant changes in the exchange rates used to settle Bolivar-denominated transactions and 2) the significant changes in the exchange rates used to remeasure our Venezuelan subsidiary's financial statements at the balance sheet dates. We believe these gains and losses are attributable to an unpredictable foreign currency environment in Venezuela. As a result, we have excluded these gains and losses and we will exclude future non-operating gains and/or losses relating to our Venezuelan subsidiary from our non-U.S. GAAP adjusted diluted net earnings per common share until such time that we believe the foreign exchange environment in Venezuela stabilizes. See "Venezuela," in "Foreign Exchange Rates," of Item 3, Quantitative and Qualitative Disclosures About Market Risk, for further discussion on Venezuela.

In the third quarter of 2009, the Company redeemed all $431.3 million of its 3% Convertible Senior Notes due 2033 and recorded a $3 million pre-tax loss. This loss represented a 0.429% call premium of $2 million and a write-down of the remaining debt issuance costs related to the issuance of these senior notes in July 2003 of $1 million.

See Note 17, "Other Expense, net," for the components and discussion of other expense, net.

Our effective income tax rate was 27.5% for the third quarter of 2010 and 28.0% for the first nine months of 2010. Our effective income tax rate was 23.6% for the third quarter of 2009 and 26.2% for the first nine months of 2009.

For the third quarter and first nine months of 2010 and 2009, our effective income tax rate was lower than the statutory U.S. federal income tax rate of 35% primarily due to our lower net effective income tax rate on foreign earnings and our domestic manufacturing deduction, partially offset by U.S. state income taxes.

For the third quarter and first nine months of 2009, our effective income tax rate was also lower than the statutory U.S. federal income tax rate of 35% primarily due to our lower net effective income tax rate on foreign earnings and the utilization of income tax credits for which no benefit had previously been recognized, partially offset by an increase in reserves relating to uncertain tax positions and U.S. state income taxes.

Our expected full year 2010 effective income tax rate is approximately 28%, without taking into account any benefit from certain U.S. tax credits that expired at December 31, 2009 and have not been extended. We estimate that our effective income tax rate for first nine months of 2010 would have been, and for the full year will be, approximately 27% if certain U.S. tax credits are extended retroactively.

The following table presents a reconciliation of U.S. GAAP diluted net earnings per common share to non-U.S. GAAP adjusted diluted net earnings per common share for the 2010 and 2009 periods.

	Third Quarter of					First Nine Months of

	2010			2009		2010			2009
U.S. GAAP diluted net earnings per common share	$	0.43		$	0.34	$	1.15		$	0.99
Net earnings effect resulting from the following:
Add / (less): Foreign currency exchange losses (gains) related to Venezuelan subsidiary, net of tax (benefit) provision of $(0.4) for the three months ended September 30, 2010 and $2.2 for the nine months ended September 30, 2010		0.01			—		(0.02	)		—
Add: Global manufacturing strategy and restructuring and other charges, net of income tax benefits of $1.1 for the three months ended September 30, 2009, $1.1 for the nine months ended September 30, 2010 and $2.9 for the nine months ended September 30, 2009		—			0.02		0.01			0.03
(Less) / add: (Gains on sale) other-than-temporary impairment of available-for-sale securities, net of income tax provision (benefit) of $0.8 for the three months ended September 30, 2010, $(1.2) for the three months ended September 30, 2009, $0.9 for the nine months ended September 30, 2010 and $(1.2) for the nine months ended September 30, 2009		(0.01	)		0.01		(0.01	)		0.01
Add: Loss on debt redemption, net of income tax benefit of $1.3		—			0.01		—			0.01

Non-U.S. GAAP adjusted diluted net earnings per common share	$	0.43		$	0.38	$	1.13		$	1.04

See Note 16, "Net Earnings Per Common Share," for further details on the calculation of U.S. GAAP basic and diluted net earnings per common share.

The information in this section sets forth material changes in and updates to material information contained in the Liquidity and Capital Resources section of Management's Discussion and Analysis of Financial Condition and Results of Operations set forth in Item 7 of Part II of our Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and should be read in conjunction with that discussion. Accordingly, the discussion that follows contains:

We recorded a charge of $850.1 million in the fourth quarter of 2002, of which $512.5 million represents a cash payment that we are required to make (subject to the satisfaction of the terms and conditions of the Settlement agreement) upon the effectiveness of a plan of reorganization in the bankruptcy of W.R. Grace & Co. We did not use cash in any period with respect to this liability. The Bankruptcy Court has conducted hearings to consider confirmation of the PI Settlement Plan and has heard closing arguments with respect to the PI Settlement Plan but additional hearings may be held by the Bankruptcy Court and the District Court to consider matters related to the PI Settlement Plan. Grace, the ACC, the FCR, and the Equity Committee have filed, as co-proponents, a proposed confirmation order with respect to the PI Settlement Plan. However, the Bankruptcy Court has not indicated whether it will confirm the PI Settlement Plan and, as indicated above, objections to the PI Settlement Plan remain pending (including objections relating to injunctions, releases and provisions as applied to us and/or that are contemplated by the Settlement agreement). We do not know whether or when a final plan of reorganization will be confirmed or become effective or whether the final plan will be consistent with the terms of the Settlement agreement.

We currently expect to fund this payment by using accumulated cash and cash equivalents and future cash flows from operations. The cash payment of $512.5 million accrues interest at a 5.5% annual rate, which is compounded annually, from December 21, 2002 to the date of payment. We have recorded this accrued interest in Settlement agreement and related accrued interest on our condensed consolidated balance sheets, and these amounts were $265 million at September 30, 2010 and $234 million at December 31, 2009. The total liability balance on our condensed consolidated balance sheets was $778 million at September 30, 2010 and $747 million at December 31, 2009. In addition, the Settlement agreement provides for the issuance of 18 million shares of our common stock. Since the impact of issuing these shares is dilutive, under U.S. GAAP, they have been included in our calculation of diluted net earnings per common share.

Tax benefits resulting from the payment made under the Settlement agreement, which are currently recorded as deferred tax assets on our condensed consolidated balance sheets, are anticipated to provide approximately $350 million of current and future cash tax benefits subsequent to the payment under the Settlement agreement. The amount and timing of future cash tax benefits could vary, depending on the amount of cash paid by us and various facts and circumstances at the time of payment under the Settlement agreement, including the price of our common stock, our tax position and the applicable tax codes.

As mentioned in "2010 Outlook" above, our full year 2010 diluted net earnings per common share guidance continues to exclude the payment of the Settlement agreement, as the timing is unknown. Payment under the Settlement agreement is expected to be accretive to our post-payment diluted net earnings per common share by approximately $0.12 to $0.14 annually. This range primarily represents the accretive impact on our net earnings from ceasing to accrue any future interest on the settlement amount following the payment.

The information set forth in Item 1 of Part I of this Quarterly Report on Form 10-Q in Note 14, "Commitments and Contingencies," under the caption "Settlement Agreement and Related Costs" is incorporated herein by reference.

The information set forth in Item 1 of Part I of this Quarterly Report on Form 10-Q in Note 14, "Commitments and Contingencies," under the caption "Cryovac Transaction Commitments and Contingencies" is incorporated herein by reference.

We require cash to fund our operating expenses, capital expenditures, interest, taxes and dividend payments and to pay our debt obligations and other long-term liabilities as they come due. Our principal sources of liquidity are cash flows from operations, accumulated cash and amounts available under our existing lines of credit described below, including the global credit facility and the European credit facility, and our accounts receivable securitization program.

We believe that our current liquidity position and future cash flows from operations will enable us to fund our operations, including all of the items mentioned above, and the cash payment under the Settlement agreement should it become payable within the next 12 months.

At September 30, 2010, there were no amounts outstanding under our global or European credit facilities, and we did not utilize these facilities in 2010.

Further information about our lines of credit, our outstanding long-term debt and the related financial covenants and limitations is provided in Note 10, "Debt and Credit Facilities."

See Note 6, "Accounts Receivable Securitization Program," for information concerning this program.

Our cost of capital and ability to obtain external financing may be affected by our debt ratings, which the credit rating agencies review periodically. The Company and our long-term senior unsecured

debt are currently rated BB+ (stable outlook) by Standard & Poor's. This rating is considered non-investment grade. The Company and our long-term senior unsecured debt are currently rated Baa3 by Moody's. This rating is considered investment grade. On May 4, 2010, Moody's revised our ratings outlook to stable from negative. If our credit ratings are downgraded, there could be a negative impact on our ability to access capital markets and borrowing costs could increase. A credit rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time by the rating organization. Each rating should be evaluated independently of any other rating.

Changes in our consolidated cash flows in the 2010 and 2009 periods were as follows:

Net cash provided by operating activities of $289 million for the nine months ended September 30, 2010 was primarily attributable to net income adjusted for non-cash items of $336 million, which included depreciation and amortization and share-based compensation expenses of $136 million. The changes in operating assets and liabilities resulted in a net cash usage of $47 million. This use was primarily due to cash used for inventories of $62 million, which was primarily due to higher inventory levels in North America and Europe mainly in our food businesses. These higher inventory levels reflected the rise in average petrochemical-based raw material costs in 2010 and a build up in inventories in anticipation of increased sales volumes from normal seasonality in these businesses.

Net cash provided by operating activities of $359 million for the nine months ended September 30, 2009 was primarily attributable to net income adjusted for non-cash items of $311 million, which included depreciation and amortization and share-based compensation expenses of $135 million. The changes in operating assets and liabilities resulted in a net cash source of $48 million, primarily due to:

Net cash used in investing activities was $57 million in the first nine months of 2010 primarily due to capital expenditures for property and equipment. Our capital expenditures in 2010 include the use of $12 million of available cash to fund the purchase of our new manufacturing facility in Brazil to expand our capacity. We anticipate additional capital expenditures related to this facility through 2011. In 2010, we also used $8 million of available cash to fund the completion of a small acquisition.

Net cash used in investing activities was also $57 million in the first nine months of 2009 primarily due to capital expenditures for property and equipment. During 2009, we completed the construction phase of GMS with the opening of our manufacturing plant in Poland.

We expect to continue to invest capital as we deem appropriate to expand our business, to maintain or replace depreciating property, plant and equipment, to acquire new manufacturing technology and to improve productivity and sales growth. Taking into account the completion of the construction phase of GMS in 2009 and our investment in a new facility in Brazil in April 2010, we now expect total capital expenditures in 2010 to be in the range of $80 million to $90 million. This range is comparable to the level of capital expenditures incurred prior to implementing GMS in 2006. This projection is based upon our capital expenditure budget for 2010, the status of approved but not yet completed capital projects, anticipated future projects and historic spending trends.

Net cash used in financing activities was $149 million in the first nine months of 2010 primarily due to the repayment of amounts outstanding under our European credit facility of $64 million in January 2010 and the payment of our quarterly dividends of $59 million.

Net cash provided by financing activities was $48 million in the first nine months of 2009 primarily due to the receipt of net proceeds of $684 million from our issuances of $300 million of 12% Senior Notes in February 2009 and $400 million of 7.875% Senior Notes in June 2009. The net cash provided by these issuances was partially offset by the redemption of the 3% Convertible Senior Notes with a face value of $431.3 million in July 2009, the retirement of our remaining outstanding $136.7 million of 6.95% Senior Notes in May 2009 and dividend payments of $57 million.

The 21% increase in working capital in the first nine months of 2010 was primarily due to the following factors:

The information set forth in Item 1 of Part I of this Quarterly Report on Form 10-Q in Note 11, "Derivatives and Hedging Activities," under the caption "Interest Rate Swaps" is incorporated herein by reference.

At September 30, 2010, we were party to foreign currency forward contracts, which did not have a significant impact on our liquidity.

The information set forth in Item 1 of Part I of this Quarterly Report on Form 10-Q in Note 11, "Derivatives and Hedging Activities," under the caption "Foreign Currency Forward Contracts" is incorporated herein by reference.

For further discussion about these contracts and other financial instruments, see Part I, Item 3, "Quantitative and Qualitative Disclosures about Market Risk."

The $198 million, or 9%, increase in stockholders' equity in the first nine months of 2010 was primarily due to the following:

For a discussion of our critical accounting policies and estimates, refer to "Management's Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Estimates" in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2009, which information is incorporated herein by reference.

We are exposed to market risk from changes in the conditions in the U.S. financial markets, interest rates, foreign currency exchange rates and commodity prices and the creditworthiness of our customers, which may adversely affect our consolidated financial position and results of operations. We seek to minimize these risks through regular operating and financing activities and, when deemed appropriate, through the use of derivative financial instruments. We do not purchase, hold or sell derivative financial instruments for trading purposes.

At September 30, 2010, we had one remaining auction rate security investment, which continues to be exposed to market risk related to changes in conditions in the U.S. financial markets and in the financial condition of the security's issuer. This security historically was re-auctioned every twenty-eight days, which had provided a liquid market for it. However, as a result of continuing liquidity concerns in the U.S. for this type of asset-backed security, every auction held by the issuer since late 2007 has failed. This investment had an original cost of $12.0 million and an estimated fair value of $10.1 million at September 30, 2010.

From time to time, we may use interest rate swaps, collars or options to manage our exposure to fluctuations in interest rates.

At September 30, 2010, we had outstanding interest rate swaps, but no outstanding collars or options.

See Note 12, "Fair Value Measurements and Other Financial Instruments," for details of the methodology and inputs used to determine the fair value of our fixed rate debt. The fair value of our fixed rate debt varies with changes in interest rates. Generally, the fair value of fixed rate debt will increase as interest rates fall and decrease as interest rates rise. A hypothetical 10% decrease in interest rates would result in an increase of $56 million in the fair value of the total debt balance at September 30, 2010. These changes in the fair value of our fixed rate debt do not alter our obligations to repay the outstanding principal amount or any related interest of such debt.

As a large, global organization, we face exposure to changes in foreign currency exchange rates. These exposures may change over time as business practices evolve and could materially impact our consolidated financial position or results of operations in the future. See Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations, above for the impacts foreign currency translation had on our operations.

Recent economic events in Venezuela have exposed us to heightened levels of foreign currency exchange risks.

As of January 1, 2010, Venezuela was considered a highly inflationary economy. Therefore we are required to remeasure the financial results of our Venezuelan subsidiary as if its functional currency was the U.S. dollar. Also, in January 2010, the Venezuelan government devalued the bolivar by resetting the official exchange rate from 2.15 bolivars per U.S. dollar to 4.3 bolivars per U.S. dollar for non-essential transactions and 2.60 bolivars per U.S. dollar for essential transactions.

On January 1, 2010 we did not have access to or permission to use the official exchange rate. Accordingly for the majority of our transactions, we accessed the parallel foreign currency exchange market (which was a rate of 5.95 bolivars per U.S. dollar at December 31, 2009) that was available to entities that did not have access to the official exchange rate. Since we did not have access to the official exchange rate at December 31, 2009, we translated our Venezuelan subsidiary's balance sheet using the parallel rate.

From time to time during 2010 our access to the official exchange rate was restricted. However, as of September 30, 2010, we had access to the Foreign Exchange Administrative Board ("CADIVI") in Venezuela. Therefore, as of September 30, 2010, we have re-measured the net bolivar-denominated monetary assets of approximately $20 million of our Venezuelan subsidiary using the official exchange rate of 4.3 bolivars per U.S. dollar. At September 30, 2010, we settled transactions at the official exchange rate. Also at September 30, 2010, our Venezuelan subsidiary had a negative cumulative translation adjustment balance included in stockholder's equity of approximately $46 million.

As a result of the changes in the exchange rates upon settlement of bolivar-denominated transactions and upon the remeasurement of our Venezuelan subsidiary's financial statements, we recognized net losses of $1 million in the third quarter of 2010 and net gains of $7 million in the first nine months of 2010.

For the first nine months of 2010, less than 1% of our consolidated net sales were derived from our business in Venezuela and approximately 2% of our consolidated operating profit was derived from our business in Venezuela.

The potential future impact to our consolidated financial position and results of operations for future bolivar-denominated transactions will depend on our access to U.S. dollars and on the exchange rates in effect when we enter into, remeasure and settle transactions. Therefore, it is difficult to predict the future impact until each transaction settles at its applicable exchange rate or gets remeasured into U.S. dollars.

We use foreign currency forward contracts to fix the amounts payable or receivable on some transactions denominated in foreign currencies. A hypothetical 10% adverse change in foreign exchange rates at September 30, 2010 would have caused us to pay approximately $25 million to terminate these contracts.

Our foreign currency forward contracts are described in Note 11, "Derivatives and Hedging Activities," which is contained in Part I, Item 1, and in "Management's Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Derivative Financial Instruments—Foreign Currency Forward Contracts," contained in Part I, Item 2 of this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.

We may use other derivative instruments from time to time, such as foreign exchange options to manage exposure due to foreign exchange rates and interest rate and currency swaps related to access to additional sources of international financing. These instruments can potentially limit foreign exchange exposure and limit or adjust interest rate exposure by swapping borrowings denominated in one currency for borrowings denominated in another currency. At September 30, 2010, we had no foreign exchange options and currency swap agreements outstanding.

Our outstanding debt is generally denominated in the functional currency of the borrowing subsidiary. We believe that this enables us to better match operating cash flows with debt service requirements and to better match the currency of assets and liabilities. The amount of outstanding debt denominated in a functional currency other than the U.S. dollar was $27 million at September 30, 2010 and $109 million at December 31, 2009.

We are exposed to credit risk from our customers. In the normal course of business we extend credit to our customers if they satisfy pre-defined credit criteria. We maintain an allowance for doubtful

accounts for estimated losses resulting from the failure of our customers to make required payments. An additional allowance may be required if the financial condition of our customers deteriorates. The allowance for doubtful accounts is maintained at a level that management assesses to be appropriate to absorb estimated losses in the accounts receivable portfolio.

Our customers may default on their obligations to us due to bankruptcy, lack of liquidity, operational failure or other reasons. Our provision for bad debt expense was $2 million in the third quarter of 2010 and $6 million in the first nine months of 2010, nominal in the third quarter of 2009 and $4 million for the first nine months of 2009. Allowance for doubtful accounts was $21 million at September 30, 2010 and $18 million at December 31, 2009.

We maintain disclosure controls and procedures, as defined in Rule 13a-15 under the Securities Exchange Act of 1934, as amended, that are designed to ensure that information required to be disclosed in our reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and that our employees accumulate this information and communicate it to our management, including our Chief Executive Officer (our principal executive officer) and our Chief Financial Officer (our principal financial officer), as appropriate, to allow timely decisions regarding the required disclosure. In designing and evaluating the disclosure controls and procedures, our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only "reasonable assurance" of achieving the desired control objectives, and management necessarily must apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

As of the end of the period covered by this report, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures under Rule 13a-15. Our management, including our Chief Executive Officer and Chief Financial Officer, supervised and participated in this evaluation. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the "reasonable assurance" level.

There has not been any change in our internal control over financial reporting during the quarter ended September 30, 2010 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

The information set forth in Item 1 of Part I of this Quarterly Report on Form 10-Q in Note 14, "Commitments and Contingencies," of Notes to Condensed Consolidated Financial Statements is incorporated herein by reference. See also Part I, Item 3, "Legal Proceedings," of our Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and Part II, Item 1, "Legal Proceedings," of our Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2010 and June 30, 2010, as well as the information incorporated by reference in those items.

See Part I, Item 1A, "Risk Factors," of our Annual Report on Form 10-K for the fiscal year ended December 31, 2009. Except as required by the federal securities law, we undertake no obligation to update or revise any risk factor, whether as a result of new information, future events or otherwise.

The SEC encourages companies to disclose forward-looking statements so that investors can better understand a company's future prospects and make informed investment decisions. Some of our statements in this report, in documents incorporated by reference into this report and in our future oral and written statements, may be forward-looking. These statements reflect our beliefs and expectations as to future events and trends affecting our business, our consolidated financial position and our results of operations. These forward- looking statements are based upon our current expectations concerning future events and discuss, among other things, anticipated future financial performance and future business plans. Forward-looking statements are identified by such words and phrases as "anticipates," "believes," "could be," "estimates," "expects," "intends," "may," "plans to," "should," "will" and similar expressions. Forward-looking statements are necessarily subject to risks and uncertainties, many of which are outside our control, that could cause actual results to differ materially from these statements.

The following are important factors that we believe could cause actual results to differ materially from those in our forward-looking statements: the implementation of our Settlement agreement regarding the various asbestos-related, fraudulent transfer, successor liability, and indemnification claims made against the Company arising from a 1998 transaction with W. R. Grace & Co.; general economic conditions, particularly as they affect packaging use; credit ratings; changes in raw material pricing and availability; changes in energy costs; competitive conditions and contract terms; currency translation and devaluation effects, including in Venezuela; the success of our growth, profitability and manufacturing strategies and our cost reduction and productivity efforts; the effects of animal and food-related health issues; pandemics; environmental matters; regulatory actions and legal matters; and the other information referenced above under Item 1A, "Risk Factors." Except as required by the federal securities laws, we undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

On August 9, 2007, we announced that our Board of Directors had approved a share repurchase program, authorizing us to repurchase in the aggregate up to 20 million shares of our issued and outstanding common stock, par value $0.10 per share. This program replaced our prior share repurchase program, which we have terminated. During the quarter ended September 30, 2010, we did not repurchase any shares of our common stock pursuant to our publicly announced program. Through

September 30, 2010, we had repurchased 4,024,400 shares of our common stock under the current program, leaving 15,975,600 shares of common stock authorized for repurchase under the program. The program has no set expiration date.

We do, from time to time, acquire shares of common stock that are (a) withheld from awards under our 2005 contingent stock plan pursuant to the provision of that plan that permits tax withholding obligations or other legally required charges to be satisfied by having us withhold shares from an award under that plan, or (b) forfeited under that plan upon failure to satisfy vesting conditions, for which no consideration is paid.

Exhibit Number			Description

	3.1		Unofficial Composite Amended and Restated Certificate of Incorporation of the Company as currently in effect. (Exhibit 3.1 to the Company's Registration Statement on Form S-3, Registration No. 333-108544, is incorporated herein by reference.)
	3.2		Amended and Restated By-Laws of the Company as currently in effect. (Exhibit 3.1 to the Company's Current Report on Form 8-K, Date of Report May 20, 2009, File No. 1-12139, is incorporated herein by reference.)
	31.1		Certification of William V. Hickey pursuant to Rule 13a-14(a), dated November 8, 2010.
	31.2		Certification of David H. Kelsey pursuant to Rule 13a-14(a), dated November 8, 2010.
	32		Certification of William V. Hickey and David H. Kelsey, pursuant to 18 U.S.C. § 1350, dated November 8, 2010.
	101.INS		XBRL Instance Document
	101.SCH		XBRL Taxonomy Extension Schema
	101.CAL		XBRL Taxonomy Extension Calculation Linkbase
	101.LAB		XBRL Taxonomy Extension Label Linkbase
	101.PRE		XBRL Taxonomy Extension Presentation Linkbase
	101.DEF		XBRL Taxonomy Extension Definition Linkbase

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


(Mark One)
ý		QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2010
Or
o		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to


Delaware (State or other jurisdiction of incorporation or organization)		65-0654331 (I.R.S. Employer Identification Number)
200 Riverfront Boulevard Elmwood Park, New Jersey (Address of principal executive offices)		07407-1033 (Zip Code)
Registrant's telephone number, including area code: (201) 791-7600


Large accelerated filer ý		Accelerated filer o		Non-accelerated filer o (Do not check if a smaller reporting company)		Smaller reporting company o


PART I. FINANCIAL INFORMATION			1
	Item 1.	Financial Statements (Unaudited)	1
		Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2010 and 2009	1
		Condensed Consolidated Balance Sheets—September 30, 2010 and December 31, 2009	2
		Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2010 and 2009	3
		Condensed Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended September 30, 2010 and 2009	4
		Notes to Condensed Consolidated Financial Statements	5
		Note 1 Organization and Basis of Presentation	5
		Note 2 Recently Issued Accounting Standards	6
		Note 3 Segments	7
		Note 4 Global Manufacturing Strategy and 2008 Cost Reduction and Productivity Program	8
		Note 5 Available-for-Sale Investments	10
		Note 6 Accounts Receivable Securitization Program	11
		Note 7 Inventories	12
		Note 8 Property and Equipment, net	13
		Note 9 Goodwill and Identifiable Intangible Assets	13
		Note 10 Debt and Credit Facilities	15
		Note 11 Derivatives and Hedging Activities	17
		Note 12 Fair Value Measurements and Other Financial Instruments	21
		Note 13 Income Taxes	24
		Note 14 Commitments and Contingencies	25
		Note 15 Stockholders' Equity	34
		Note 16 Net Earnings Per Common Share	37
		Note 17 Other Expense, net	38
	Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	40
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	60
	Item 4.	Controls and Procedures	63
PART II. OTHER INFORMATION			64
	Item 1.	Legal Proceedings	64
	Item 1A.	Risk Factors	64
		Cautionary Notice Regarding Forward-Looking Statements	64
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	64
	Item 6.	Exhibits	65
Signature			66
Certifications

			September 30, 2010		December 31, 2009

Assets:
	Trade receivables, net, and finished goods inventory, net
		Food Packaging	$	429.9	$	401.2
		Food Solutions		209.2		210.6
		Protective Packaging		301.8		266.1
		Other		60.3		57.9

	Total segments and other			1,001.2		935.8
	Assets not allocated			4,570.4		4,484.3

	Total		$	5,571.6	$	5,420.1

	Three Months Ended September 30,				Nine Months Ended September 30,

	Three Months Ended September 30,				Nine Months Ended September 30,				Cumulative Through September 30, 2010
	2010		2009		2010		2009		Cumulative Through September 30, 2010
Capital expenditures	$	0.4	$	5.2	$	2.6	$	16.6	$	155.3
Associated costs(1)		0.4		2.3		3.2		7.6		35.5
Restructuring and other charges(2)		0.1		0.3		1.0		0.8		39.3


Restructuring accrual at December 31, 2009	$	9.4
Provision for termination benefits		1.1
Adjustment to accrual for termination benefits		(0.1	)
Cash payments during 2010		(9.2	)
Effect of changes in foreign currency rates		(0.4	)

Restructuring accrual at September 30, 2010	$	0.8

		Estimated Fair Value at December 31, 2009		Net Unrealized Gains		Other-than- temporary Impairment			Proceeds from Sales			Gains On Sales		Estimated Fair Value at September 30, 2010

Auction rate securities:
	Debt instrument with contractual maturity dates in 2012, 2033 and 2036	$	13.5	$	0.2	$	(0.6	)	$	(5.1	)	$	2.1	$	10.1
	Non-cumulative perpetual preferred stock		0.2		—		(0.1	)		(1.1	)		1.0		—

Total		$	13.7	$	0.2	$	(0.7	)	$	(6.2	)	$	3.1	$	10.1

			September 30, 2010			December 31, 2009			September 30, 2009

Inventories (at FIFO, which approximates replacement value):
	Raw materials		$	96.7		$	90.1		$	92.3
	Work in process			123.7			97.2			112.6
	Finished goods			369.4			326.3			357.5

		Subtotal (at FIFO)		589.8			513.6			562.4
Reduction of certain inventories to LIFO basis				(50.7	)		(44.2	)		(49.2	)

	Total		$	539.1		$	469.4		$	513.2

	September 30, 2010			December 31, 2009

Land and improvements	$	53.3		$	49.7
Buildings		626.6			604.1
Machinery and equipment		2,329.8			2,332.0
Other property and equipment		110.9			124.1
Construction-in-progress		49.4			42.7

		3,170.0			3,152.6
Accumulated depreciation and amortization		(2,204.7	)		(2,141.9	)

Property and equipment, net	$	965.3		$	1,010.7

	September 30, 2010			December 31, 2009

Gross carrying value	$	109.9		$	116.8
Accumulated amortization		(34.7	)		(58.4	)

Total	$	75.2		$	58.4


Fourth quarter of 2010	$	2.7
2011		8.4
2012		6.7
2013		5.6
2014		4.9
Thereafter		15.9

Total	$	44.2

	September 30, 2010		December 31, 2009

Used lines of credit	$	25.7	$	107.1
Unused lines of credit		912.9		846.3

Total available lines of credit	$	938.6	$	953.4

Available lines of credit—committed	$	675.8	$	686.1
Available lines of credit—uncommitted		262.8		267.3

Total available lines of credit	$	938.6	$	953.4

Accounts receivable securitization program—committed(1)	$	95.0	$	74.0

	September 30, 2010			December 31, 2009

Available lines of credit	$	262.8		$	267.3
Unused lines of credit		237.1			224.4
Weighted average interest rate		7.8	%		5.5	%

September 30, 2010		Total Fair Value		Level 1		Level 2		Level 3

Cash equivalents		$	149.9	$	140.9	$	9.0	$	—

Available-for-sale securities		$	10.1	$	—	$	—	$	10.1

Derivative financial instruments net asset:
	Interest rate swaps	$	11.2	$	—	$	11.2	$	—

	Foreign currency forward contracts	$	2.5	$	—	$	2.5	$	—

December 31, 2009		Total Fair Value		Level 1		Level 2		Level 3

Cash equivalents		$	65.0	$	—	$	65.0	$	—

Available-for-sale securities		$	13.7	$	—	$	—	$	13.7

Derivative financial instruments net liability:
	Interest rate swaps	$	0.5	$	—	$	0.5	$	—

	Foreign currency forward contracts	$	3.6	$	—	$	3.6	$	—


Estimated fair value as of December 31, 2009		$	13.7
Net unrealized gains included in other comprehensive income			0.2
Other-than-temporary impairment included in earnings			(0.7	)
Proceeds from sale of available-for-sale securities			(6.2	)
Gains on sales included in earnings			3.1

	Estimated fair value as of September 30, 2010	$	10.1

	September 30, 2010				December 31, 2009

	Carrying Amount		Fair Value		Carrying Amount		Fair Value
5.625% Senior Notes due July 2013	$	399.6	$	423.4	$	399.4	$	416.0
12% Senior Notes due February 2014(1)		311.2		357.8		299.5		372.5
7.875% Senior Notes due June 2017		392.4		434.0		391.8		424.0
6.875% Senior Notes due July 2033		448.5		393.8		448.5		423.0
Other foreign loans		27.1		26.9		109.0		115.4
Other domestic loans		9.1		9.1		12.8		23.8

Total debt	$	1,587.9	$	1,645.0	$	1,661.0	$	1,774.7

	2010		2011		2012		2013		Total

2010 Three-year PSU Awards	$	0.8	$	3.0	$	3.0	$	—	$	6.8
2009 Two-year and Three-year PSU Awards		4.9		7.8		—		—		12.7
Other long-term share-based compensation programs		2.6		7.2		4.9		1.0		15.7

Total share-based compensation	$	8.3	$	18.0	$	7.9	$	1.0	$	35.2

Third Quarter of 2010		U.S.					International					Total Company

Volume—Units		$	32.7		6.5	%	$	18.1		3.1	%	$	50.8		4.7	%
Volume—Acquired businesses, net of (dispositions)			(1.8	)	(0.3	)		(0.3	)	(0.1	)		(2.1	)	(0.2	)
Product price/mix			14.3		2.9			(2.8	)	(0.5	)		11.5		1.1
Foreign currency translation			—		—			(10.1	)	(1.7	)		(10.1	)	(1.0	)

	Total	$	45.2		9.1	%	$	4.9		0.8	%	$	50.1		4.6	%

First Nine Months of 2010		U.S.					International					Total Company

Volume—Units		$	79.2		5.4	%	$	59.9		3.7	%	$	139.1		4.5	%
Volume—Acquired businesses, net of (dispositions)			(1.8	)	(0.1	)		(1.7	)	(0.1	)		(3.5	)	(0.1	)
Product price/mix			(1.6	)	(0.1	)		(27.1	)	(1.7	)		(28.7	)	(0.9	)
Foreign currency translation			—		—			77.6		4.8			77.6		2.5

	Total	$	75.8		5.2	%	$	108.7		6.7	%	$	184.5		6.0	%

	September 30, 2010			December 31, 2009			Increase

Working capital (current assets less current liabilities)	$	774.5		$	639.6		$	134.9
Current ratio (current assets divided by current liabilities)		1.5	x		1.4	x
Quick ratio (current assets, less inventories divided by current liabilities)		1.2	x		1.1	x


	SEALED AIR CORPORATION
Date: November 8, 2010	By:	/s/ JEFFREY S. WARREN Jeffrey S. Warren Controller (Duly Authorized Executive Officer and Chief Accounting Officer)